The effects of a neurosteroid, pregnenolone sulfate, in the cerebellum on vestibulo-ocular reflex adaptation (VOR) in goldfish by Cox, Michele Margaret
  
 
 
The Effects of a Neurosteroid, Pregnenolone Sulfate, in the Cerebellum on 
Vestibulo-Ocular Reflex Adaptation (VOR) in Goldfish 
 
A Thesis 
Submitted to the Faculty 
of 
Drexel University 
by 
Michele Margaret Cox 
In partial fulfillment of the 
requirements for the degree 
of 
Doctor of Philosophy 
June 2006 
 ii 
 
 
 
COPYRIGHT 
 
 
 
© Copyright 2006 
Michele Margaret Cox.  All Rights Reserved. 
 iii 
 
 
 
Dedication 
 
 
 
 
 
Cynthia Proctor-Cox 
 
I thank God everyday for blessing me with a mother as wonderful 
as you.  Thank you for all your love, support and the sacrifices you made, 
none of this could have been possible without you.  I Love You! 
 iv 
 
 
 
Acknowledgments 
 
 
 I would like to thank James G. McElligott, Ph.D. for his support, guidance, 
teachings and insight.  This journey that we have made together has had its ups and 
downs, but you never gave up hope on me and always pushed me to do better than I 
thought I could and I truly thank you. 
 I would like to thank Ronald Tallarida, Ph.D. for “kidnapping” me from Drexel 
and bringing me over to Temple to do my research.  It has truly been a pleasure knowing 
you and thank you for all the help with my statistics. 
 I am truly grateful to my adopted mother, Phyllis Beeton, for listening to all my 
problems, her scientific critic of my experiments, help in performing my experiments, 
celebrating my triumphs and accomplishments and encouraging me through the tough 
times.  I Love You! 
 I would like to thank Barrie Ashby, Ph.D. for being so generous in allowing me to 
collaborate with him, for his sharing his scientific expertise with me, for his support and 
motivation as we counted down to this very day. 
 I would like to thank my dissertation committee: Drs. Fred Allen, Barrie Ashby 
(Temple Medical School), William Freedman, Karen Moxon and Malcolm Taylor (U. of 
Deleware) for your participation as my dissertation examiners and for your constructive 
criticism and suggestions. 
 To my adopted family at the Department of Pharmacology at Temple Medical 
School, whom I have harassed at one time, or another and who have shared my joys and 
 v 
tears, I am forever blessed to have known you.  Special thanks go to Drs. James Daniel, 
Zhe Ding, Saadet Inan and Jennifer Werkheiser for you encouragement and friendship.  
To Carol Dangelmaier and Mary McCafferty who have touched my life.  To the ladies of 
the offices both at Drexel and Temple: Tracy Burton, Diane Durr, Caryn Glaser, Lakisha 
Goodman, Liz Molina and Lisa Williams—thanks for all the support and encouragement. 
 To: Jennifer Albano, Mai Bui, Troy Carter, Ph.D., Milind Ghandi, M.D., 
Maimouna Kone, Deanah Mitchell, Ph.D., Tom Parry, Ph.D., Patricia Quinter, Amir 
Rezvan, M.D., Anna Shmuelson, Dafydd Thomas and Loretta Williams-Walker, Ph.D. 
thank your for your guidance and friendship. 
 I’d like to acknowledge the love and support of my aunt and uncle, Margaret and 
Allan James to whom I will be forever indebted.  To:  Giselle Bernard, Natacha Noel, 
Merissa Sutton and Sheryl Williams thanks for always being in my corner.  Through all 
of you I have been truly blessed and you will always be in my heart. 
 vi 
 
 
 
Table of Contents 
LIST OF TABLES ............................................................................................. x 
LIST OF FIGURES ............................................................................................ xi 
ABSTRACT  .......................................................................................... xiii 
1. INTRODUCTION .......................................................................................1 
 A. Thesis Objectives and Summary.............................................................1 
 B. Introduction/Background ........................................................................4 
  B.1  Vestibulo-Ocular Reflex Adaptation..............................................4 
  B.2  Cerebellar Involvement of the 
          Vestibulo-Ocular Reflex Adaptation .............................................7 
  B.3  Cerebellar Neuropharmacology of the  
          Vestibulo-Ocular Reflex Adaptation .............................................8 
  B.4  Biosynthesis of Neurosteroids......................................................13 
  B.5  Steriodogenic Acute Regulatory Protein (StAR) .........................15 
  B.6  Memory Enhancing Effects from Administration 
          of PREGS.....................................................................................16 
  B.7  Inhibitory Amino Acid & Excitatory Amino Acid 
         Pharmacology in the Cerebellum..................................................16 
  B.8  Inhibitory Neurotransmitters ........................................................17 
  B.9  Excitatory Neurotransmitters .......................................................21 
  B.10 Synaptic Plasticity .......................................................................23 
  B.11 Statement of Work ......................................................................34 
2. METHODS AND MATERIALS 
 Subjects and Initial Set Up Procedures ......................................................36 
 vii 
 Experimental Equipment and Behavioral Procedures ...............................40 
  Vestibular And Visual Apparatus ...........................................................40 
  Procedures ............................................................................................40 
 Eye Movement Measurements...................................................................41 
 Data Analysis ............................................................................................41 
  Sinusoidal Stimulation............................................................................41 
 Microdialysis Procedures...........................................................................42 
 Microinjection Procedures (Acquisition)...................................................43 
 Microinjection Procedures (Retention)......................................................46 
 Hisotolgy ............................................................................................47 
 Immunohistochemical analysis with  
 cytochrome P-450scc antibody..................................................................47 
 GSI Sample Collection ..............................................................................48 
 Statistics ............................................................................................49 
3. The Effects of Pregnenolone Sulfate on the Acquisition Phase of 
 Vesibulo-Ocular Reflex Adaptation ..........................................................51 
 A. Introduction...........................................................................................51 
 B. Results ............................................................................................52 
   B.1 Normal Vis-VOR and VOR Gain Before and After Cerebellar 
   Control and Drug Infusion (Microdialysis) ...........................................53 
   B.2 Normal Vis-VOR and VOR Gain Before and After Cerebellar 
   Control and Drug Infusion (Microinjection)..........................................54 
   B.3 Effect of PREGS on Adaptive Vis-VOR and VOR Gain Increases 
       (Microdialysis).................................................................................54 
   B.4 Effect of PREGS on Adaptive Vis-VOR and VOR Gain Decreases 
       (Microdialysis).................................................................................58 
 viii 
   B.5 Effect of PREGS on Adaptive Vis-VOR and VOR Gain Increases 
        (Microinjection) ..............................................................................59 
   B.6 Effect of PREGS on Adaptive Vis-VOR and VOR Gain Decreases 
        (Microinjection) ..............................................................................67 
   B.7 Effect of PREGS on Adaptive VOR Gain Increase After First Being 
         Trained to Decrease Adaptive VOR Gains (Microinjection) ..........72 
 C. Discussion ............................................................................................73 
4. The Effects of Pregnenolone Sulfate on the Retention Phase of 
 Vesibulo-Ocular Reflex Adaptation ..........................................................85 
 A. Introduction...........................................................................................85 
 B. Results ............................................................................................88 
    B.1 Effect of PREGS on the Retention Phase of Adapted Gain Increase 
        When Infused Before Adaptation ...................................................88 
    B.2 Effect of PREGS on the Retention Phase of Adapted Gain Decrease 
        When Infused Before Adaptation ...................................................90 
    B.3 Effect of PREGS on the Retention Phase of Adapted Gain Increase 
        When Infused After Adaptation......................................................90 
    B.4 Effect of PREGS on the Retention Phase of Adapted Gain Decrease 
        When Infused After Adaptation......................................................91 
 C. Discussion ............................................................................................93 
5. Evolutionary Conservation of Cytochrome-P540 Side Chain Cleavage 
 Enzyme ............................................................................................97 
 A. Introduction...........................................................................................97 
 B. Results ............................................................................................99 
 C. Discussion ............................................................................................99 
6. Seasonal Changes in the Gonadosomatic Index of Goldfish ...................102 
 A. Introduction.........................................................................................102 
 B. Results ..........................................................................................103 
 ix
 C. Discussion ..........................................................................................103 
7. Conclusions 
 A. Summary and Conclusions..................................................................106 
    A.1 Effect of PREGS on the Normal Vis-VOR and VOR Reflex 
         (Microdialysis).............................................................................106 
    A.2 Effect of PREGS on the Normal Vis-VOR and VOR Reflex 
    (Microinjection) ...........................................................................109 
    A.3 Effect of PREGS on the Acquisition Phase of VOR 
    Adaptation (Microdialysis) ..........................................................109 
 
    A.4 Effect of PREGS on the Acquisition Phase of VOR 
    Adaptation (Microinjection) ........................................................110 
    A.5 Effect of PREGS on Adaptive VOR Gain Increase After First Being 
           Trained to Decrease Adaptive VOR Gains (Microinjection) ......111 
    A.6 Effect of PREGS on the Retention Phase of Adapted Gain Decrease 
    When Infused Before Adaptation ................................................111 
    A.7 Effect of PREGS on the Retention Phase of Adapted Gain Decrease 
    When Infused After Adaptation...................................................112 
 B. Vestibulo-Ocular Reflex Adaptation and Pregnenolone Sulfate.........112 
    B.1 Increase Acquisition.....................................................................116 
    B.2 Decrease Acquisition....................................................................118 
    B.3 Increase Versus Decrease Acquisition .........................................119 
    B.4 Increase Retention ........................................................................120 
    B.5 Decrease Retention.......................................................................122 
    B.6 Increase Versus Decrease Retention ............................................122 
 C. Cytochrome P450scc...........................................................................123 
 D. Neurosteroids and Disorders of Learning and Memory......................123 
 x
 E. Goldfish Vestibulo-Ocular Reflex Compared to 
   Mammalian Systems............................................................................124 
 F. Conclusions..........................................................................................125 
LIST OF REFERENCES.....................................................................................127 
APPENDIX A: ABBREVIATIONS....................................................................163 
APPENDIX B: DEFINITIONS ...........................................................................169 
VITA     ..........................................................................................170 
 xi
 
 
 
List of Tables 
1. Normal vestibulo-ocular reflex gain prior to adaptive training toward 
 3X (Microdialysis) .....................................................................................56 
2. Normal vestibulo-ocular reflex gain prior to adaptive training toward 
 0X (Microdialysis) .....................................................................................56 
3. Normal vestibulo-ocular reflex gain prior to adaptive training toward 
 3X (Microinjection) ...................................................................................57 
4. Normal vestibulo-ocular reflex gain prior to adaptive training toward 
 0X (Microinjection) ...................................................................................57 
5. Adapted increase VOR gains for various concentrations of 
 PREGS vs. CSF-control.............................................................................62 
6. Adapted decrease VOR gains for various concentrations of 
 PREGS vs. CSF-control.............................................................................65 
7. Adapted increase VOR gains for various concentrations of 
 PREGS vs. CSF-control.............................................................................70 
8. Adapted decrease VOR gains for various concentrations of 
 PREGS vs. CSF-control.............................................................................76 
9. Reversal of adapted decrease VOR gains for various concentrations 
 of PREGS vs. CSF-control ........................................................................78 
10. Gonadosomatic indices (GSI) in goldfish during different periods 
 of their reproductive cycle .......................................................................105 
 xii
 
 
 
List of Figures 
1. Vestibulo-Ocular Reflex Neural Circuitry...................................................6 
2. The biosynthesis of steroid hormones........................................................12 
3. Head-block Construction ...........................................................................37 
4. Eye Movement Measurements...................................................................39 
5. Microdialysis Probe and Probe Placement in Cerebellum.........................44 
6. Microinjection Probe and Probe Placement in Cerebellum.......................45 
7. Individual Effect of PREGS on Adaptive VOR Gain Increases 
 (Microdialysis)...........................................................................................60 
8. Effect of PREGS on Adaptive VOR and Vis-VOR Gain Increases 
 (Microdialysis)...........................................................................................61 
9. Individual Effect of PREGS on Adaptive VOR Gain Decreases 
 (Microdialysis)...........................................................................................63 
10. Effect of PREGS on Adaptive VOR and Vis-VOR Gain Decreases 
 (Microdialysis)...........................................................................................64 
11. Individual Effect of PREGS on Adaptive VOR Gain Increases 
 (Microinjection) .........................................................................................68 
12. Effect of PREGS on Adaptive VOR and Vis-VOR Gain Increases 
 (Microinjection) .........................................................................................69 
13. Individual Effect of PREGS on Adaptive VOR Gain Decreases 
 (Microinjection) .........................................................................................74 
14. Effect of PREGS on Adaptive VOR and Vis-VOR Gain Decreases 
 (Microinjection) .........................................................................................75 
15. Effect of PREGS on Adaptive VOR Gain Increase After First Being 
 Trained to Decrease Adaptive VOR Gains (Microdialysis) ......................77 
16. Effect of PREGS on the Retention Phase of Adapted Gain Increases 
 & Decreases When Infused Before Adaptation .........................................89 
 xiii 
17. Effect of PREGS on the Retention Phase of Adapted Gain Increases 
 & Decreases When Infused After Adaptation ...........................................92 
18. Localization of P450scc-like immunoreactive cells in the brain .............100 
19. Seasonal Changes in GSI in Goldfish......................................................105 
20. Effect of PREGS on Normal Reflex Increases and Decreases 
 (Microdialysis).........................................................................................107 
21. Effect of PREGS on Normal Reflex Increases and Decreases 
 (Microinjection) .......................................................................................108 
22. Effects of PREGS on Vestibulo-Ocular Reflex Adaptation ....................113 
23. Cerebellar Cortex .....................................................................................115 
 xiv
 
 
 
Abstract 
The Effects of a Neurosteroid, Pregnenolone Sulfate, on Vestibulo-Ocular Reflex 
Adaptation (VOR) in Goldfish 
Michele Margaret Cox 
William Freedman, Ph.D. (Advisor) 
James G. McElligott (Co-Advisor) 
 
 
 
 
 The vestibulo-ocular reflex (VOR) is an evolutionarily well conserved system that 
stabilizes visual images on the retina during rapid head movement.  Adaptation of the 
VOR has served as a model system for sensori-motor learning and memory, as well as 
neuroplastic phenomena within the cerebellum.  The results presented in this thesis 
investigated the effects of pregnenolone sulfate (PREGS) on the acquisition (learning) 
and retention (memory) phases of VOR adaptation.  PREGS significantly enhanced the 
acquisition phase of adaptive VOR gain increases (104% via microdialysis, 101% via 
microinjection), but not adaptive VOR gain decreases when infused into the cerebellum 
of goldfish without altering normal operation of this reflex prior to the initiation of 
adaptive training.  In addition, PREGS did not significantly reverse adaptive VOR gain 
decreases.  The summation of these results suggests that the distinct properties of 
adaptive VOR gain increases and decreases are mediated by different pharmacological 
mechanisms and/or possibly at different neuronal sites.  PREGS did not enhance nor 
inhibit the retention phase of adaptive VOR gain increases or decreases when infused into 
the cerebellum of goldfish.  These results suggest that these two adaptation tasks 
(acquisition and retention) could also occur by different pharmacological mechanisms 
and/or their site of adaptation resides in different anatomical structures (cerebellum for 
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acquisition, vestibular nuclei for retention).  In addition, we demonstrated that a 
cytochrome P-450scc-like protein is present in the cerebellum of goldfish, specifically in 
the Purkinje cell layer; suggesting that these cells possess the enzyme cytochrome P-
450scc and produce pregnenolone and PREGS.  This work agrees with earlier studies in 
which this enzyme specific for the formation of pregnenolone has been detected and 
localized in the cerebellar Purkinje cells of both higher and lower vertebrates, suggesting 
that cytochrome P-450scc is a highly conserved protein. 
  
1 
CHAPTER 1: INTRODUCTION 
A.  Thesis Objectives and Summary 
 The prime aim of the research presented in this thesis was to investigate the 
effects of the neurosteroid, pregnenolone sulfate, on sensori-motor neural plasticity in 
vivo.  Specifically, we investigated the influence of the steroid hormone, pregnenolone 
sulfate, on vestibulo-ocular reflex adaptation for both adaptive gain increases and 
decreases during the acquisition (learning) and retention (memory) phases in goldfish 
(Carassius auratus).  A second aim of the thesis was to determine the mechanism of 
action of pregnenolone sulfate in the cerebellum of goldfish.  These goals were 
accomplished by modification of the chosen experimental model system, the vestibulo-
ocular reflex (VOR).  This system was chosen for several reasons:  
1) the neuroanatomical organization of this reflex has been thoroughly investigated (Ito, 
1984), 
(2) the reflex can be easily modified by sensory stimuli, 
(3) modification of the reflex has a well established time course, and 
(4) characteristics of the reflex have been evolutionarily conserved across a variety of 
species. 
 The third aim of this research was to determine whether the enzymatic mechanism 
involved in pregnenolone formation was evolutionarily conserved.  To accomplish this 
goal immunohistochemical techniques were used to detect and localize the presence of 
cytochrome P450 side-chain cleavage enzyme (cytochrome P450scc), a crucial enzyme 
necessary in the biosynthesis of neurosteroids, in the brain of goldfish. 
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 The VOR has served as a superior model for the study of sensori-motor 
integration and adaptation in the central nervous system (CNS).  Adaptation of this reflex 
provides us with a model system to investigate neuroplastic phenomena in the brain and 
to study mechanisms of learning and memory in sensori-motor systems (du Lac et al., 
1995).  Adaptation is defined as the modification or change in the operation of the reflex  
However, a great deal still remains to be learned about the anatomical and 
pharmacological basis of VOR adaptation.  Investigations locating the neuronal site(s) 
responsible for the behavioral adaptation of the VOR have implicated two CNS areas; the 
cerebellum and the vestibular nuclei complex in the brain stem (Lisberger, 1994b; du Lac 
et al., 1995).  Experimental evidence supports the view that the cerebellum is the 
neuronal site where adaptive changes occur (Demer & Robinson, 1982; Ito, 1994; Miles 
& Lisberger, 1981a; .Watanabe, 1984).  However, there is another hypothesis that 
indicates that neuroplastic changes associated with VOR adaptation occur external to the 
cerebellum (Miles & Lisberger, 1981a) 
 The behavioral studies presented in this thesis investigated cerebellar 
neuropharmacological mechanisms involved with the normal operation and adaptation of 
the vestibulo-ocular reflex by means of microdialysis or microinjection of pregnenolone 
sulfate into the cerebellum of goldfish.  There is one related study in which the 
relationship between neurosteroids and vertigo was examined Yamamoto, T. et al., 1998).  
In this electrophysiological study the effects of pregnenolone sulfate was examined on 
the activity of medial vestibular nucleus (MVN) neurons type I and II.  This study 
demonstrated that the iontophoretic application of pregnenolone sulfate dos-dependently 
increased the spontaneous firing of both type I and type II neurons differentially, 
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suggesting a disturbance of the harmony of the vestibulo-ocular reflex with ensuing 
development of vertigo.    To date, no one has attempted to address the effects of 
pregnenolone sulfate on the vestibulo-ocular reflex when infused in the vestibulo-
cerebellum on goldfish. In addition, our pharmacological approach allows for a more 
controlled infusion of the drug in comparison to previous studies in which pregnenolone 
sulfate was administered systemically (see B. Introduction/Background: Memory 
Enhancing Effects from Administration of PREGS). 
 We chose to investigate VOR adaptation in goldfish because this animal exhibits 
robust oculomotor performance with eye movements comparable with those observed in 
mammals (Easter 1972; Pastor et al.; 1992; Schairer & Bennett 1986).  Goldfish  produce 
large and rapid gain changes of 3.0 – 3.5X, in contrast to other animals that produce 
smaller adaptive changes (rabbits 1.1 -1.2X, cats 1.5X, monkeys 1.7 X and humans 1.9 – 
2.0X).  However, the anatomical organization of the VOR reflex in goldfish shares many 
similarities with mammals.  Goldfish have a vestibulo-cerebellar region that is 
comparable to the vestibulo-cerebellar region (flocculus) in mammals.  Afferent and 
efferent organizations as well as basic firing patterns of Purkinje cells in this region are 
similar to those found in mammals.  VOR eye movements in goldfish are elicited during 
swimming and involve detection of horizontal head rotation about the vertical axis by the 
horizontal semicircular canals.  Horizontal conjugate eye movements are produced by the 
lateral and medial rectus eye muscles in the horizontal plane.  The neuronal circuitry 
mediating this reflex involves the classical 3 neuron arc, along with the specialized 
abducens internuclear pathway.  In addition, there has been extensive work in goldfish 
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investigating the pharmacological basis of VOR adaptation in the cerebellum of goldfish.  
For these reasons goldfish make an ideal model for studying VOR eye movements. 
B.  Introduction/Background 
    1.  Vestibulo-Ocular Reflex Adaptation 
 The VOR, because of its close relationship with the cerebellum and its marked 
adaptiveness, has become a model system for studying the functions of the cerebellum.  
The VOR stabilizes visual targets on the center of an animal’s visual field in order to 
maintain clear vision during rapid head motion by producing equal, but opposite eye 
movements with respect to the head.  The “gain” of this reflex refers to the magnitude 
(position) of eye movement compared to that of the head.  Adaptation of the VOR occurs 
when the visual target input from the climbing fibers does not match the vestibular/head 
rotation input from the mossy fibers.  This mismatch produces slippage of visual targets 
and therefore the VOR must modify itself in order to maintain visual clarity.  Voluntary 
visual following is often not adequate to compensate for these head movements, because 
the visually associated neuronal process involved is a slower control system compared to 
the VOR.  The VOR is considered to be the phylogenetically oldest and most primitive 
subsystem mediated by the oculomotor system. 
 In the cerebellum, the horizontal VOR neuronal circuitry utilizes both positive 
and negative feedback systems and is regulated by a three-neuron arc (Fig 1.1).  
Stimulation of the horizontal semicircular canals on either side of the head sends neural 
signals via primary vestibular nerve fibers to the relay cells of the VOR located in the 
vestibular nucleus.  Collaborative influence of afferent signals from both the climbing 
fibers and mossy fibers modulates cerebellar Purkinje cells (PC) that in turn send 
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neuronal signals to the vestibular nucleus.  These vestibular cells then send either 
excitatory or inhibitory signals to the motor neurons in the abducens and oculomotor 
nuclei.  The result is that both eyes move in the direction opposite to that of the head 
rotation and correct the effects of head rotation thus stabilizing images on the retina or 
related structure (i.e., area centralis for cats).  The main feature of this vestibulo-
cerebellar pathway is that cerebellar PCs project monosynaptic inhibitory (GABA) 
influences on vestibular neurons in the brainstem (Voogd and Glickstein, 1998; 
Ghelarducci et al.; 1975; Simpson and Alley, 1974). 
 Changes during development or injury require that the VOR be modifiable in 
order for visual clarity to be maintained.  Adaptation of the VOR occurs when there is a 
mismatch of the vestibular and visual stimuli.  At times it may be necessary to suppress 
this reflex, for example when reading a book on a train.  If there is a sudden change in the 
motion of train, the momentum will cause the head to undergo acceleration, stimulating 
the peripheral vestibular end-organs.  In this case it would not be appropriate for the eyes 
to move since the book is held stationary with respect to the head.  Therefore, the reflex 
must be canceled to minimize motion of the eyes with respect to the head and book.  
There are also times in our daily activities when the eyes should move in the opposite 
direction, but with a greater degree of rotation than the head, for example, when wearing 
eyeglasses.  The lenses of the eyeglasses in combination with those of the eye create a 
telescope with a positive magnification.  The resulting eye movement must be of greater 
magnitude than the movement of the head in order to avoid image blurring.  Changes 
during development, aging or injury require that the VOR be modifiable in order for 
visual clarity to be maintained. 
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Figure 1.1. Vestibulo-Ocular Reflex Neural Circuitry 
Simplified circuitry diagram of the vestibulo-ocular reflex and modulation pathway via 
the cerebellum. 
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    2.  Cerebellar Involvement in Vestibulo-Ocular Reflex Adaptation 
 The cerebellum is a brain structure that has been well conserved over hundreds of 
millions of years and is specific to vertebrates.  The cerebellar cortex is composed of five 
main types of neurons, granule cells, (located in the granule layer), Purkinje cells and 
three types of inhibitory interneurons, the Golgi cells, the stellate and basket cells (found 
in the molecular layer).  The cerebellum receives information about peripheral events and 
central processes predominantly from climbing and mossy fibers.  The vestibulo-
cerebellum (i.e., flocculus, nodulus, and uvula) is the area within the cerebellum that 
receives and processes these peripheral events. 
 Studies involving vestibulo-cerebellum ablation or cerebellectomy have shown 
that adaptive VOR gain changes are inhibited or lost following these types of lesions 
(Robinson, 1974; Robinson, 1976; Mchnovicz and Bennet, 1987; Pastor et al., 1994).  
However, lesions on the nodulus, uvula, or posterior vermis did not significantly alter the 
VOR adaptation (Cohen et al.; 1992).  A study in which lidocaine was directly 
microdialyzed into the vestibulo-cerebellum also demonstrated an inhibition of adaptive 
VOR gain changes (McElligott et al.; 1998).  These results suggest that the flocculus is 
the main site for VOR adaptation (the “flocculus hypothesis).  The flocculus has a direct 
connection with a basic reflex circuit, the vestibulo-ocular reflex.  The flocculus 
hypothesis (Ito, 1972) suggest that the flocculus is the center for adaptive control that 
modifies the dynamics of the vestibulo-ocular reflex by means of error signals from the 
retina, suggesting that the cerebellum functions as the site where adaptability of the reflex 
occurs.  However, it has been argued by Miles and Lisberger (1981), that the flocculus is 
not the major site for VOR adaptation; it simply helps by passing the relevant information 
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to the extracerebellar site of plasticity in the brainstem.  Recently another hypothesis 
regarding VOR adaptation has emerged.  This hypothesis suggests that the sites for motor 
learning for the VOR lie in both the brainstem and cerebellum (Lisberger, 1994a; du Lac 
et al.; 1995). 
    3.  Cerebellar Neuropharmacology of the Vestibulo-Ocular Reflex 
 In an effort to understand the normal and adaptive mechanisms involved in the 
VOR, a number of pharmacologic treatments have been employed (i.e., GABA 
(Fukushima et al.; 1993; McElligott et al.; 2002 acetylcholine (Tan and Collewijn, 1991, 
1992a); noradrengergic transmitters (Keller and Smith, 1983, McElligott & Freedman, 
1988; Tan et al.; 1991 van Neerven et al.; 1990).  The work reported in this thesis is one 
of the first to demonstrate an enhancement of adaptive VOR gain changes.  The above 
reported studies have demonstrated an inhibition of the VOR by various agents on these 
receptors. 
 Gamma-aminobutyric Acid (GABA).  In the cerebellum, GABA is the primary 
transmitter of inhibitory interneurons such as the basket and Golgi cells.  GABA is also 
released by the Purkinje cells onto the brain stem vestibular neurons in response to 
stimulation of the VOR pathway.  van Neervan and colleagues (1991) demonstrated that 
injection of muscimol (GABAA agonist) and baclofen (GABAB agonist) into the 
flocculus of rabbits significantly reduced the normal gain of the VOR.  Similar results 
were demonstrated, following cerebellar injections of muscimol in cats (Fukushima et al.; 
1993).  A recent study by McElligott et al.;(2003) showed that microdialysis of both 
muscimol and baclofen directly into the vestibulo-cerebellum inhibited adaptive VOR 
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gain increases and decreases.  These studies suggest that both GABAA and GABAB are 
important in VOR adaptation. 
 Acetylcholine (Ach).  Administration of cholinergic agonists and antagonists into 
the flocculus has been shown to affect the VOR.  Bilateral injection of a non-specific 
acetylcholine agonist, carbachol, in Dutch rabbits significantly elevated normal VOR, but 
not Vis-VOR gain during sinusoidal stimulation (Tan & Collewijn, 1991).  However, Tan 
and Collewijn were unable to duplicate their results obtained with carbachol following 
floccular injections (Tan & Collewijn, 1992b).  It has been concluded based on the results 
of these studies that acetylcholine has minimal action in the flocculus on the VOR. 
 Biogenic Amines.  Norepinephrine is one of the biogenic amines that is 
considered to be involved with neuroplastic phenomena, most notably with hippocampal 
long-term potentiation (LTP) and with developmental plasticity in the visual cortex.  
Several studies have investigated the effects of norepinephrine on adaptation of the VOR.  
Norepinephrine is believed to modulate the gating mechanisms of individual cells located 
in the cerebellum. 
 Studies performed by Keller and Smith (1983) and McElligott and Freedman 
(1988) demonstrated that intra-cisternal injection of the neurotoxin 6-hydroxy-dopamine, 
which depleted central stores of norepinephrine, in cats inhibited their ability to produce 
adaptive VOR gain changes.  These results illustrate the effect of extensive CNS 
depletion of norepinephrine on VOR adaptation. 
 Studies have also shown the role of serotonin as well as norepinephrine depletion 
on adaptive VOR gain changes.  Depletion of serotonin and norepinephrine by 
intraventricular injection of 5,7-dihydroxytryptamine in rabbits demonstrated an 
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inhibition of VOR adaptation (Miyashita & Watanabe, 1984).  These results did not agree 
with above studies carried out on cats and the possible lack of sufficient norepinephrine 
depletion or species differences may account for this difference. 
 In another study, bilateral injections of the β-adrenergic receptor agonist, 
isoproterenol, into the flocculus of rabbits enhanced adaptive VOR gain increases (van 
Neerven et al.; 1990).  In addition, bilateral injections of the β-adrenergic receptor 
antagonist, sotalol, into the flocculus of rabbits inhibited adaptation of the VOR (van 
Neerven et al.; 1990).  Both drugs caused no changes in the normal operation of the 
reflex.  Previously our laboratory demonstrated that injection of the non-specific β-
adrenergic receptor antagonist, propranolol, into the vestibulo-cerebellum of goldfish 
inhibited adaptive VOR gain increases, but not adaptive VOR gain decreases (Williams 
& McElligott,). 
 Another study tested the effect of specific α-adrenergic compounds on the VOR 
(Tan et al.; 1991).  The results illustrated that injection of various α-adrenergic 
compounds into the flocculus of rabbits did not have an effect on the VOR.  Thereby, it 
was concluded that the α-adrenergic receptors, though prominent in the cerebellum, do 
not participate in the normal operation or adaptation of the reflex. 
 Steroids.  Steroid hormones supplied by the peripheral steroidogenic glands or 
locally synthesized regulate several important brain neuronal functions during 
development which persist into adulthood in vertebrates.  Steroids formed from 
cholesterol in vertebrate brains are called neurosteroids.  The brain content of these 
steroids remains constant even after the removal of peripheral steroids by procedures 
such as adrenalectomy, castration and hypophysectomy.  This would suggest that the 
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brain can synthesize steroids de novo (Corpéchot et al., 1981, 1983; Robel and Baulieu, 
1985; Robel et al.; 1986, 1987; Jo et al.; 1989).  Extensive studies have shown that both 
mammalian and non-mammalian vertebrates (i.e. avian and amphibians species) produce 
steroids de novo from cholesterol in the brain (Mensah-Nyagan et al.; 1994; Tsutsui and 
Yamakai, 1995; Usui et al.; 1995; Vanson et al.; 1996; Tsutsui et al.; 1997a, b). 
 In mammals the glial cells play a major role in neurosteroid formation and 
metabolism in the brain.  Both oligodendrocytes and astrocytes are considered to be the 
primary sites for pregnenolone synthesis, an initial step of neurosteroidogenesis (Takase 
et al., 1999).  Recent studies have demonstrated that the Purkinje cells possess 
neurosteroidogenic enzymes and produce neurosteroids de novo in a variety of 
vertebrates including mammalian species (Usui et al.; 1995, Tsutsui et al.; 1997a, b; 
Ukena et al.; 1998, 1999a; Takase et al.; 1999). 
 Several studies from our laboratory have investigated the influence of steroid 
hormones on adaptation of the VOR (McElligott & Taylor, 1999).  We were able to 
demonstrate that microdialysis of estradiol enhanced adaptive gain increases, but not gain 
decreases in a dose dependent manner when infused in the cerebellum of goldfish.  
However, the infusion of testosterone, progesterone and 17α-20β progesterone did not 
enhance nor inhibit adaptive VOR gain changes.  We concluded that the reason for these 
marked differences between steroids may be due to the metabolite formation of these 
different steroids. It was for this reason that we decided to take a closer look at the 
synthesis of these hormones to see if another steroid may have similar effects on VOR 
adaptation as estradiol. 
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Figure 1.2. The biosynthesis of steroid hormones. 
The biosynthesis of steroid hormones begins with the synthesis of pregnenolone from 
cholesterol, which eventually derives the sex steroids.  Route A: pregnenolone can be 
converted directly to progesterone and thence to aldosterone.  Route B: pregnenolone can 
be converted to 17α-hydroxypregnenolone, which is the precursor for cortisol formation.  
Route C: pregnenolone can be converted to 17α-hydroxypregnenolone, which is the 
precursor for sex-related steroids.  Pregnenolone sulfate is formed from pregnenolone by 
sulfotransferases and can be converted back to the parent substance by sulfatases. 
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    4.  Biosynthesis of Neurosteroids 
 Pregnenolone, a 3β-hydroxy-∆5- steroid, is the main precursor of steroid 
hormones secreted by steroidogenic glandular cells.  The biosynthesis of pregnenolone is 
initiated by the enzymatic cleavage of the cholesterol side-chain by cytochrome P450scc 
(CYP XIA1)-linked monooxygenase system, which is located on the matrix side of the 
inner mitochondrial membrane (Fig 1.2).  The rate-limiting step of steroidogenesis is the 
delivery of cholesterol to the inner mitochondrial membrane (Lambeth et al.; 1987; 
Privalle et al.; 1987) and not the production of pregnenolone as previously believed 
(Stone and Hechter, 1954; Karaboyas and Koritz, 1965). 
 Several species of mammals have been reported to have abundant quantities of 
pregnenolone, its fatty acid or sulfate esters in the brain.  The content of these steroids in 
the brain remains constant even after the removal of peripheral steroids by procedures 
such as adrenalectomy, castration and hypophysectomy.  Tsutsui and Yamazaki (1995) 
measured the concentrations of pregnenolone and its sulfate ester in the whole brain of 
adult quail using a specific radioimmunoassay (RIA).  Pregnenolone concentration in 
adult quail was much higher in the brain than in the plasma.  Hypophysectomy greatly 
reduced plasma pregnenolone concentrations, but a high level of pregnenolone persisted 
in the brain.  This would suggest that the brain can synthesize pregnenolone largely 
independently of peripheral steroidogenic glands and stimulation by adrenocorticotrophic 
hormone (ACTH). 
 Takase et al.; (1999) used RIA to investigate the distribution of pregnenolone and 
its sulfate ester (pregnenolone sulfate, PREGS) in the brain of lower vertebrates.  The 
results indicated that the concentrations of pregnenolone and PREGS of Xenopus laevis, 
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(frog), were significantly higher in the brain, particularly the cerebellum, than in the 
gonads and plasma.  In addition, Takase et al.; (1999) examined the seasonal changes in 
the concentrations of pregnenolone and PREGS in the brain of Rana nigromaculata, a 
seasonally breeding amphibian.  In both sexes, PREGS concentrations were higher during 
the breeding season (female), post-breeding season (males) and low during the 
hibernating season for both sexes, whereas, the concentration of pregnenolone remained 
constant in the brain throughout the year.  Taking all this together it could be suggested 
that (1) both pregnenolone and PREGS contribute as major neurosteroids to some 
cerebellar function in the amphibian brain and (2) the seasonal change in PREGS 
concentrations observed in the brain may indicate its independence of peripheral 
steroidogenic glands, since there was a clear difference between the concentrations in the 
plasma and brain. 
 Pregnenolone sulfate has been reported to influence the activity of several 
different ligand-gated ion-channel receptors: it blocks activation of GABAA receptors 
(Majewska et al.; 1987, 1988, 1992; Lambert et al.; 1990; Lan et al.; 1990; Morrow et al.; 
1990; Puia et al.; 1990; Rabow et al.; 1995; Shingai et al.; 1991), glycine (Wu et al.; 
1990), AMPA and kainate receptors and it potentiates activation of N-methyl-D-aspartate 
(NMDA) receptors (Wu et al.; 1991; Bowlby 1993; Irwin et al.; 1992, 1994; Fahey et al.; 
1995).  The mechanism of action and physiological role of PREGS in the brain is not 
known.  It is speculated that pregnenolone sulfate may (1) modulate GABAergic 
transmission by means of the paracrine action on GABAergic neurons (2) act directly on 
membrane sites or (3) directly modulate ionotropic receptors or Ca2+ channels. 
 
  
15 
    5.  Steriodogenic Acute Regulatory Protein (StAR) 
 Steriodogenic acute regulatory protein (StAR) is a 30-kDa protein involved in the 
transport of cholesterol to the inner mitochondrial membrane and thus plays a pivotal role 
in steroid biosynthesis.  StAR expression is acutely regulated by trophic hormones 
(Juengel et al.; 1995; Sugawara et al.; 1997).  Cyclic AMP influences StAR gene 
expression, as it does many proteins important for steroidogenesis (Belfiore et al.; 1994; 
Payne and Youngblood, 1995; Chen & Menon, 1994).  Arakane et al.; (1996) reported 
that the C-terminal end of StAR proteins stimulate pregnenolone synthesis and therefore 
contains the domains that are functionally important for stimulation of steroidogenesis. 
 It was recently discovered that StAR, localized at the contact sites between the 
outer and inner mitochondrial membranes, induces steroid production in MA-10 cells 
(Clark et al.; 1994; King et al.; 1995).  RNAase assays clearly identified StAR transcripts 
in rat brain.  StAR mRNA was expressed in all brain regions, but there was a strong 
signal observed in the hippocampus (Furukawa et al.; 1998).  In situ hybridization studies 
found abundant StAR transcripts in the cerebral cortex, the pyramidal cell layers of the 
hippocampus and dentate gyrus, and the olfactory bulb.  Of all the brain regions the 
cerebellum expressed the highest level of StAR mRNA.  Within the cerebellum, StAR 
transcripts were predominately expressed in the Purkinje cells and only moderately in the 
granule cells and stellate/basket cells (Furukawa et al.; 1998).  Furthermore, in situ 
hybridization studies revealed that mRNAs of three steroidogenic proteins are co-
expressed in single Purkinje cells.  Co-expression of StAR, cytochrome P450scc and 3β-
hydroxysteroid dehydrogenase (3β-HSD) have been revealed in the pyramidal cells in the 
hippocampus and in the Purkinje and granule cells in the cerebellum.  King et al.; (1995) 
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reported that StAR synthesis is not inhibited when cytochrome P450scc activity is 
blocked by aminoglutethimide (AMG), indicating that StAR is not produced as a result of 
feedback inhibition.  These results provide anatomical and functional support to the 
hypothesis that neurosteroid biosynthesis might be directly regulated in specific regions 
of the brain, independent on the contribution of adrenal steroidal precursors. 
    6.  Memory Enhancing Effects from Administration of PREGS 
 Many studies have examined the effects of post-acquisition or pre-retention 
hormone and/or drug administration on learning and memory processes (McGaugh, 1989; 
van Wimersma Greidanus, 1970, 1989), although relatively few investigations have 
targeted the role of sex steroids or their precursors in such paradigms.  Pregnenolone and 
its derivatives have been reported to have memory enhancing effects on mice (Flood et 
al.; 1992, 1995; Frye & Sturgis 1995; Isaacson et al.; 1995; Mathis et al.; 1996; Mezine et 
al.; 1996).  Moreover, it has been reported that the concentrations of pregnenolone sulfate 
in the blood is markedly decreased with age in humans, especially in subjects diagnosed 
with Alzheimer’s disease (Weill-Engerer et al.; 2002). 
    7.  Inhibitory Amino Acid & Excitatory Amino Acid Pharmacology in the Cerebellum 
 As mention previously (page 15 last paragraph), PREGS influences several 
receptors for neurotransmitters: it blocks activation of GABAA receptors, glycine, AMPA 
and kainate receptors and it potentiates activation of N-methyl-D-aspartate receptors.  
Both inhibitory and excitatory neurotransmitters play important roles in the cerebellum.  
Mossy fibers are one of two main sources of excitatory input to the cerebellum.  Mossy 
fibers enter the granule layer from their main point of origin, the pontine nuclei.  These 
fibers form excitatory synapses with the glomeruli of the granule cells.  The granules 
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cells send their T-shape axons, known as parallel fibers, up to the molecular layer where 
they form synapses with the Purkinje cell dendrites.  The second main source of 
excitatory input to the cerebellum comes from the climbing fibers, which originate from 
the inferior olivary nucleus.  Each Purkinje cell dendrite receives input from a single 
climbing fiber in the form of a powerful excitatory signal.  The Purkinje cells serve as the 
sole output of the cerbellar cortex and projects monosynaptic inhibitory (GABA) 
influences on vestibular neurons in the brainstem.  The GABAA receptors have been 
found to be expressed by granule cells and Purkinje cells within the cerebellum (Laurie et 
al.; 1992a; Persohn et al.; 1992; Wisden et al.; 1996).  Adult rat cerebellar Purkinje cells 
express NMDA receptors only during their development (Crepel et al.; 1983; Audinat et 
al.; 1990; Llano et al.; 1991; Krupa & Crepel, 1990; Dupont et al.; 1987).  However, 
NMDA receptors are expressed in the granule cell layer of the cerebellum (Monaghan & 
Beaton, 1991; Ebert et al.; 1991; O’Shea et al.; 1991; Beaton et al.; 1992) and 
presynaptically in the molecular layer (Gibbs et al.; 1999). 
    8.  Inhibitory Neurotransmitters 
 GABA Receptor.  GABA is the major inhibitory amino acid transmitter of the 
mammalian central nervous system and it is present in some 40% of all neurons.  GABA 
is synthesized from the amino acid glutamate by glutamic acid decarboxylase (Dawson et 
al.; 2005).  The GABAA receptor belongs to the superfamily of fast-acting ligand-gated 
chloride ion channels.  When the receptor is stimulated, GABA binds to the “GABA 
ionophore” allowing chloride ions to enter the cell producing a hyperpolarization of the 
post-synaptic membrane and decreasing the probability of an action potential.  The 
GABAA receptor-ion channel complex is a heteropentameric glycoprotein, composed of a 
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combination of multiple polypeptide subunits (Nayeem et al.; 1994; Im et al.; 1995; 
Wisden et al.; 1996).  There are many subunits of the GABAA receptor found in the 
central and peripheral nervous systems.  At present there are 19 identified subunits and at 
least 18 genes coding for these subunits (α1-6 β1-4 γ1-3 δ, ε, θ ρ1-2).  These receptors differ 
in the following ways: affinity for neurotransmitter, desensitization rate and channel 
conductance.  Although the exact composition of native GABAA receptor is unknown, 
the subunit composition of the GABAA receptors varies from one brain region to another 
and even between neurons in a given region (Wisden et al.; 1996).  The major GABAA 
subunit genes expressed by granule cells are α, α6, β2, β3, γ2 and δ (Wisden et al.; 
1996).  It is unclear whether the α1 and α6 subunits are in the same receptor complex 
(e.g. α1  α6  β2  γ2), if they are in parallel receptors (e.g. α1  β2 γ2 and α6  β2 γ2) or if all 
three combinations are found.  In situ hybridization studies have demonstrated that α1, 
β2, β3 and γ2 GABAA subunit genes are strongly expressed in Purkinje cells (Laurie et 
al.; 1992a; Persohn et al.; 1992; Wisden et al.; 1996).  The stellate and basket 
interneurons are purely GABAergic neurons.  These cells are likely to account for a 
significant number of GABAA receptors and express a α1 β2 γ2 combination, as 
determined by in situ hybridization (Laurie et al.; 1992a, Persohn et al.; 1992, Miralles et 
al.; 1994). 
 GABAA receptors play a pivotal role in regulation of brain excitability and can 
exist in at least three different conformations: open, closed and desensitized.  GABAA 
receptor function can be modified by diverse classes of therapeutic compounds.  
Presently 14 different ligand binding sites have been proposed to account for the 
modulation of the GABAA receptor (Tsang & Xue, 2004).  The benzodiazepines, because 
  
19 
of their therapeutic importance, have been a major focus of GABAA receptor research.  
All the overt effects of benzodiazepines: sedative, anxiolytic, anticonvulsant, muscle 
relaxant and amnesic are produced via the GABAA receptors.  However, not all the 
GABAA receptors recognize the benzodiazepines.  The possession of a particular type of 
α subunit (1, 2, 3, or 5) together with a γ subunit and a β subunit is required to confer 
sensitivity in order for “classical” benzodiazepine recognition (Duncalfe et al.; 1996, 
Wieland et al.; 1992).  Agonist benzodiazepine site ligands increase channel opening 
frequency. 
 Interestingly, the compound ethyl β-carboline-3-carboxylate (β-CCE) whose 
effects are diametrically different than those of classical benzodiazepines, i.e. it is pro-
convulsant, was one of the first non-benzodiazepine ligands discovered to displace the 
benzodiazepines from their binding sites.  β-CCE has been termed an inverse agonist with 
the classical benzodiazepines being classified as agonists.  Inverse agonists decrease the 
potency of the natural transmitter thereby decreasing channel opening frequency (Barker 
et al.; 1984; Sigel, 2002) 
 Barbiturates also produce many of their effects by interaction with the GABAA 
receptors.  Barbiturates augment the GABA mediated current by increasing average 
channel open time, but have little effect on channel opening frequency (Study & Barker, 
1981; Twyman et al.; 1989).  Unlike benzodiazepines, barbiturates can open GABAA 
receptors channels directly at high concentrations (Nicoll et al.; 1975; Simmonds, 1981). 
 In addition, the GABAA receptors also exhibit high affinity recognition sites for 
certain steroids.  Certain steroids facilitate GABA mediated responses via recognition 
sites distinct from both the barbiturates and the benzodiazepines.  These steroids produce 
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their effects by increasing both channel open time and opening frequency (Twyman & 
Macdonald, 1992).  These steroids are often termed neuroactive steroids.  Among the 
antagonists are picrotoxin, which blocks the channel pore and bicuculline, which 
occupies the GABA site and prevents GABA from activating the receptor.  The 
antagonist flumazenzil is used medically to reverse the effects of the benzodiazepines. 
 The GABAB receptors are metabotropic transmembrane receptors that are linked 
via G-proteins to potassium channels (Chen et al.; 2005).  GABAB receptors are widely 
distributed within the central nervous system (CNS) and in peripheral autonomic 
terminals (Bowery et al.; 1981; Martin & Dunn, 2002).  Activation of these receptors 
stimulates the opening of potassium channels which brings the neuron closer to the 
equilibrium potential of potassium, hyperpolarizing the neuron.  This results in sodium 
channels not opening, action potentials not firing and keeeps voltage-dependent calcium 
channels’ (VDCC) from opening, thus stopping the release of the neurotransmitter.  
GABAB receptors can also reduce the activity of adenylyl cyclase and decrease the cell’s 
conductance of calcium ions upon its activation (Siegel et al.; 1999; Martin & Dunn, 
2002). 
 GABAB receptors are similar in structure to and in the same receptor family with 
metabotropic glutamate receptors (MRC, 2003).  There are two subtypes of the receptor 
GABAB1 and GABAB2 (Purves et al.; 2001; Martin & Dunn 2002).  These receptors 
appear to assemble as heterodimers in neuronal membranes by linking up their 
intracellular C termini (Martin & Dunn, 2002; MRC, 2003).  Baclofen is a GABA 
analogue selective for GABAB receptors.  Saclofen and phaclofen are selective 
antagonists. 
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 Glycine Receptor.  The strychnine-sensitive glycine receptor appears to be 
structurally homologous to the subunits of other ligand-gated ion channels, including the 
GABAA receptor.  The native glycine receptor appears to have a pentameric structure.  
Both glycine and strychnine binding sites are located on the α subunit.  Presently, there 
are four α subunit variants that have been identified (α
 1-4) and they differ in their 
pharmacological properties as well as expression levels.  In neonatal mice the α
 2 subunit 
(strychnine-insensitive) switches to the adult α
 1 form approximately 2 weeks postnatally.  
This switch corresponds with the development of spasticity in the mutant spastic mouse, 
suggesting that insufficient expression of the adult strychnine-sensitive isoform may 
cause some forms of spasticity.  Activation of the glycine receptors allows chloride ions 
to enter the neuron via ionotropic receptors, causing an inhibitory post-synaptic potential 
(IPSP). 
    9.  Excitatory Neurotransmitters 
 NMDA Receptor.  NMDA receptors play an important role in neurotransmission 
throughout the central nervous system.  Activation of the receptor and concurrent 
depolarization results in a slow-rising, long-lasting current mediated primarily by the 
influx of calcium ions.  NMDA receptors generally co-exist with either amino-3-
hydroxy-5-methyl-4-isoxazole propionate (AMPA) or kainic acid (KA) receptors.  At 
resting potentials, NMDA channels are normally blocked by magnesium ions.  There 
must be sufficient concurrent depolarization of the post-synaptic neuronal membrane 
(approximately -30mV) before the magnesium ion block is removed.  This allows the 
NMDA channel to contribute to the electrical response of the cell.  The level of 
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concurrent depolarization is dependent on AMPA/KA activation and/or other modulatory 
post-synaptic signals controlling depolarization. 
 The NMDA receptor is composed of two different protein subunits, namely 
NMDAR1 and NMDAR2.  NMDAR1 can exist in seven splice variants and there are four 
different gene encoding variants of NMDAR2 (NMDAR2A, -B, -C, and –D).  The NMDA 
receptor, like the GABAA receptor, is a complex molecular entity endowed with a 
number of distinct recognition sites for endogenous and exogenous ligands, each with 
discrete binding domains.  The binding of glycine at a strychnine-insensitive modulatory 
site potentiates the frequency of channel opening.  Glycine binding seems to be a 
necessary requirement for NMDA channel activation.  The receptor/channel complex 
also contains a polyamine regulatory site whose activation by spermine and spermidine 
facilitates NMDA receptor mediated transmission by increasing channel opening 
probability. 
 Non-NMDA Receptors.  Both amino-3-hydroxy5-methyl-4isoxazole propionate 
(AMPA) and kainic acid (KA) mediate fast excitatory synaptic transmission and are 
associated primarily with voltage-independent channels.  These receptors open ion 
channels that are permeable to sodium and potassium ions (Ascher & Nowak, 1988; 
Vyklicky et al.; 1988; Collingridge & Lester 1989) and have low permeability to calcium 
ions (Mayer & Westbrook, 1987a; Collingridge & Lester 1989).  The AMPA receptors 
have a high prominence in the hippocampus (CA1 region), outer cerebral cortex layer, 
the lateral septum and the molecular layer of the cerebellum.  The kainic acid receptors 
are most prominent in the hippocampus (CA3 region), inner cerebral cortex layer, the 
striatum, the thalamus and the granule layer of the cerebellum.  Robinson & Coyle, 1987 
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demonstrated that selective NMDA receptor competitive and non-competitive antagonists 
were ineffectual in blocking the effect of AMPA and kainite, suggesting the existence of 
both these receptors independent from the NMDA receptor.  Therefore, they have been 
more appropriately termed non-NMDA receptors.  AMPA and quisqualate are the 
preferred agonists for the AMPA receptor.  Domoate and kainite the preferred agonists 
for the kainic acid receptors.  The most potent and selective non-NMDA antagonists are a 
series of dihydroxyquinoxaline derivative which include 2,3-dihydro-6-nitro-7-
sulfamoyl-benzo(F)quinoxaline (NBQX), 6-cyan-7-nitroquinoxaline-2,3-dione (CNQX) 
and 6,7-dinitroquinoxaline-2,3-dione (DNQX). 
    10.  Synaptic Plasticity 
 Synaptic plasticity refers to the process by which synapses are modified in 
structure and function in response to different stimuli or environmental cues.  Activity-
dependent synaptic plasticity is thought to underlie many seemingly diverse processes, 
such as learning and memory (Bear & Malenka 1994), formation of proper synaptic 
connections during development (Constantine-Paton & Cline 1998; Fitzsimonds & Poo 
1998) and the manifestation of pathological conditions in the CNS (Ben-Ari & Represa 
1990; Crepel et al.; 1993). 
 The classical models for studying activity-dependent synaptic plasticity are long-
term potentiation (LTP) and long-term depression (LTD), which represent, respectively, 
an increase and a decrease in synaptic strength.  LTP represents a cellular model for 
synaptic plasticity (Brown et al.; 1988; Nicoll et al.; 1988) and is characterized by its 
long duration of action (hours to days) versus the relatively short duration of other types 
of post-tetanic stimulation (seconds to minutes).  LTD, an in vitro model of 
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neuroplasticity, is the opposite of LTP.  It is a prolonged reduction in the efficacy of 
synaptic transmission. 
 Hippocampal LTP at Excitatory Synapses.  Although NMDA receptors are widely 
distributed throughout the brain, they are concentrated in the cerebral cortex, basal 
ganglia and the CA1 region of the hippocampus.  NMDA receptors allow the passage of 
Na+ (sodium), K+ (potassium) and Ca2+ (calcium) ions and are normally blocked by Mg2+ 
(magnesium).  These channels only open in response to glutamate when the postsynaptic 
cell membrane is depolarized, thereby relieving a Mg2+ block.  Simultaneous firing of the 
presynaptic and postsynaptic cells would result in the release of glutamate into the 
synaptic cleft by the presynaptic cell at the same time that the postsynaptic membrane is 
depolarizing, the two conditions needed to cause the NMDA receptors to open.  NMDA 
activation is essential for the induction of LTP in many, but not all, pathways in the 
hippocampus.  LTP is inhibited in hippocampal CA1 recordings when pharmacological 
agents specifically blocked NMDA receptors from opening.  D-2-amino-5-
phosphonopentanoic acid (D-AP5), a competitive NMDA receptor antagonist, was shown 
to selectively and reversibly prevent the induction of LTP in the Schaffer collateral 
pathway, the perforant pathway from the entorhinal cortex to the dentate gyrus and the 
mossy fiber pathway from the dentate gyrus to the CA3 pyramidal cells (Davies et al., 
1981; Harris et al.; 1984).  This would suggest that NMDA receptor signaling in the 
postsynaptic cell is crucial for the formation of LTP.  However, NMDA receptors are not 
required for its maintenance, although the mechanism for LTP maintenance is not yet 
fully understood. 
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 An interesting property of NMDA receptors is that they not only allow Na+ and 
K+ to enter the postsynaptic cell, but also Ca2+, suggesting that Ca2+ is crucial to the 
induction of LTP.  The addition of Ca2+ chelators into the postsynaptic cells prevents 
LTP induction.  This would suggest that infux of Ca2+ through NMDA receptors is 
critical for the induction of LTP in the hippocampus.  Interestingly, prohibiting Ca2+ 
influx through NMDA receptor channels, while promoting Ca2+ influx through other 
voltage-gated channels, prevents LTP induction (Kelso et al. 1986).  Taken together one 
might conclude that the entry of Ca2+ through voltage-gate channels is not involved in 
hippocampal LTP. 
 Hippocampal LTP at Inhibitory Synapses.  Only recently have there been 
considerable efforts to characterize the mechanisms by which synaptic changes are 
triggered and expressed at inhibitory synapses.  LTP at inhibitory synapses have been 
reported in the hippocampus (Stelzer et al.; 1987, 1994; Wang & Stelzer 1996; McLean 
et al.; 1996; Caillard et al.; 1999a; Gubellini et al.; 2001).  However, relatively little is 
known about its induction.  Most studies investigating LTP at inhibitory synapses have 
focused primarily on the GABAergic synapses.  Fast synaptic inhibition in the 
mammalian brain is mediated mainly by the iontropic GABAA receptor (Macdonald & 
Olsen, 1994; Sieghart, 1995).  These receptors are widely distributed throughout the 
CNS, with sites of high receptor densities at postsynaptic membranes (Killisch et 
al.;1991; Fritschy et al.; 1992; Craig et al.; 1994; Nusser et al.; 1998).  When the receptor 
is stimulated, Cl- (chloride ions) enters the cell causing hyperpolarization of the 
postsynaptic membrane.  Since the Cl- equilibrium potential is near the resting potential 
in most neurons, increasing Cl- permeability decreases the depolarizing effects of an 
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excitatory input, thereby depressing excitability.  These receptors only open in response 
to the release of GABA by the presynaptic cell into the synaptic cleft.  
 There has been growing evidence that GABAA receptor cell surface number can 
be dynamically regulated.  Insulin treatment (Wan et al.; 1997) and the kindling model of 
epileptogenesis (Nusser et al.; 1998) have been shown to increase GABAA receptor 
surface numbers, whereas agonist treatment (Barnes, 1996; Tehrani & Barnes, 1997) and 
kinase activation (Moss & Smart, 1996; Chapell et al.; 1998; Connolly et al.; 1999b) 
reduce GABAA receptor levels.  In addition, blocking clathrin-dependent endocytosis of 
GABAA receptors results in an increase GABAA receptor surface number (Kittler et al.; 
2000).  However, the precise mechanisms that underlie these changes in the GABAA 
receptor activity remains to be elucidated.  Also, there is evidence that postsynaptic 
GABAA receptors are associated with nonfunctional presynaptic terminals in 
hippocampal cultures (Kannenberg et al.; 1999), suggesting the existence of 
presynaptically silent GABAergic synapses. 
 Hippocampal LTD at Excitatory Synapses.  Relatively little is known of 
hippocampal LTD in comparison to LTP.  It is well established that Ca2+ entry through 
the NMDA receptor is essential for the induction of LTP in the hippocampus.  
Interestingly, this same step has been shown to be necessary for the induction of LTD 
(Mulkey & Malenka 1992).  Although the induction of LTD in the hippocampus requires 
postsynaptic Ca2+, its source is less certain and may depend on influx from NMDA 
receptor channels (Mulkey & Malenka 1992; Dudek & Bear 1992; Abraham & Wickens 
1991), VDCCs (Wickens & Abraham 1991), or internal Ca2+ release after activation of 
metabotropic glutamate receptors (mGluRs) (Kato 1993; Stanton et al.; 1991).  The 
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metabotropic glutamate receptor differs from the excitatory amino acid receptors.  The 
mGluR is linked to a pertussis toxin-sensitive G-protein (Masu et al.; 1991; Houamed et 
al.; 1991) that stimulates phosphoinostide (PI) hydroplysis (Conn et al.; 1994).  In turn, 
this produces inositol triphsophate (IP3) as a second messenger, leading to the release of 
Ca2+ from internal stores and the production diacylglycerol and protein kinase C 
(Schoepp et al.; 1990). 
 Many years ago it was proposed that the mGluRs may play a role in the induction 
of LTD, particularly in early postnatal development.  There is growing evidence that 
supports this hypothesis, based on studies in which LTD was prevented by using (R,S)-a-
methyl-4-carboxyphenylglycine (MCPG), a selective mGluR antagonist (Bolshakov & 
Siegelbaum 1994).  In addition, MCPG blocked LTD induction in a fully reversible 
manner.  This would suggest that mGluRs are necessary for the induction, but not the 
expression or maintenance of LTD because MCPG did not block LTD after it had been 
induced.  However, there is also evidence that no deficit occurs in the induction of LTD 
during MCPG application (Selig et al.; 1995).  Moreover, mice lacking the gene for 
mGluR1 apparently have normal LTD in the hippocampus (Aiba et al.; 1994).  Tests for 
the involvement of mGluR5, which are highly expressed by CA1 pyramidal neurons 
await development of new pharmacological and genetic tools.  The hypothesis remains 
viable, but untested. 
 When it is effective in blocking LTD, MCPG may be acting presynaptically.  
Studies have reported that the selective, but broad spectrum, mGluR agonist trans-1-
aminocyclopentane-1,3-dicarboxylic acid (trans-ACPD) reduces glutamate release from 
Schaffer collateral (Baskys & Malenka 1991) and GABA release from CA1 interneurons 
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(Desai et al.; 1994).  MCPG partially reverses these effects (Watkins & Collingridge 
1994).  LTD induction is very sensitive to changes in excitation and inhibition and it is 
therefore not surprising that a drug that interferes with the regulation of neurotransmitter 
release would also affect LTD. 
 Ca2+ entry into the postsynaptic cell can also occur through VDCCs.  However, 
there is conflicting evidence about the involvement of these channels in the induction of 
LTD.  Evidence has demonstrated that an L-type Ca2+ channel antagonist nimodipine, but 
not D-2-amino-5-phosphonopentanoic acid (D-AP5; NMDA antagonist), was effective in 
blocking LTD in neonates (Bolshakov & Siegelbaum 1994).  However, it has also been 
reported that D-AP5, but not an L-type Ca2+ channel antagonist nifedine, blocked LTD 
induction in newborn animals of the same age range (Selig 1995).  In addition, Ca2+ 
channel antagonists have been reported to be ineffective in blocking LTD and 
depotentiation in older animals (Mulkey & Malenka 1992; Bashir & Collingridge 1994; 
Kerr & Abraham 1995). 
 Hippocampal LTP at Inhibitory Synapses.  In many ways the conditioning 
protocols for the induction of LTD at GABAergic synapses are similar to those of LTP at 
glutamategic synapses: 1) both require simultaneous firing of the pre- and postsynaptic 
cells and 2) both require a postsynaptic rise in Ca2+ concentration.  In addition, these 
protocols are dependent upon the stage of development.  Although a postsynaptic rise in 
intracellular Ca2+ concentration appears to be a common trigger for inducing synaptic 
plasticity, the source of Ca2+ and the underlying consequences on synaptic efficacy 
differs.  The induction of LTD at GABAergic synapses requires a postsynaptic rise in 
Ca2+ that is caused, at least in part, by Ca2+ influx via NMDA receptors (Caillard et al.; 
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1999).  There is evidence that the induction of LTD also requires the activation of pre- & 
postsynaptic ryanodine-sensitive Ca2+ stores.  The addition of ruthenium red or ryanodine 
to postsynaptic cells prevented the induction of LTD (Caillard et al.; 2000).  In rutherium 
red- and ryanodine-loaded cells the amplitude or membrane depolarization generated by 
titanic stimulation (TS) did not differ from that induced in controls conditions (Caillard et 
al.; 2000).  This suggests that unspecific effects on postsynaptic NMDA receptors, which 
must be activated for the induction of LTD, could be ruled out.  Additionally, bath 
application of ryanodine, which permeates both presynatic and postsynaptic membranes, 
did block the induction of LTD (Caillard et al.; 2000).  Postsynpatic infusion of 
ryanodine did not block LTD unless postsynaptic rises in Ca2+ were induced before 
(Caillard et al.; 2000).  Taken together these results suggest that the induction of LTD 
requires the activation of pre- & postsynaptic ryanodine-sensitive Ca2+ stores as well as 
activation of the NMDA receptors.  However, further research is needed to clarify the 
mechanisms leading to the activation of these Ca2+ stores. 
 Cerebellar LTP at Excitatory Synapses.  LTD of excitatory synaptic transmission 
between parallel fibers (PF) and the Purkinje cells (PC) is the most widely studied and 
best understood form of synaptic plasticity within the cerebellar cortex.  In recent years, it 
has become apparent that PF-PC synapses can also maintain a form of LTP.  This 
potentiation resembles that observed in the hippocampus between mossy fibers and CA3 
pyramidal cells (Nicoll & Malenka 1995).  Unlike LTD, which is considered to be a 
postsynaptic process, LTP is thought to result from an increasein presynaptic transmitter 
release via a mechanism involving Ca2+, cyclic adenosine 3’5’-monophosphate (cAMP) 
and protein kinase A (PKA). 
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 Several pieces of evidence support the view that potentiation at the PF-PC 
synapse is primarily of presynaptic origin.  LTP induced through raised frequency PF 
activation is accompanied by a reduction in paired pulse facilitation in slices (Salin et al.; 
1996).  Potentiation of transmitter release could also be detected in neighboring glial cells 
(Linden 1997).  Pharmacological activation of the cAMP/PKA cascade with forskolin 
(Chen & Regehr 1997) or application of the NO donor spermine NONOate induced a 
form of potentiation that shares a number of properties with synaptically induced LTP 
and leads to an increase in mEPSC frequency.  Assuming that LTP at this synapse is 
presynaptic, there are two ways in which transmitter release may effectively be enhanced: 
1) the probability of transmitter release for a given presynatpic stimulus may increase 
and/or 2) the number of release sites may rise (Zucker 1973, 1989; Manabe et al.; 1993; 
Chen & Regehr 1997; Atluri & Regehr 1998). 
 Previously it was concluded that NMDA receptors were not involved in cerebellar 
LTP (Salin 1996).  However, it was recently reported that NMDA receptors, which are 
located on presynaptic PF terminals (Petralia et al.; 1994), may enhance Ca2+ influx 
associated with PF activity leading to NOS activation and consequently a depression of 
synaptic transmission through a postsynaptic cyclic guanosine monophate (cGMP)-
dependent process (Casado et al.; 2000).  Moreover, it was reported that potentiation was 
prevented by the NMDA receptor antagonist, D-AP5. 
 LTP was also shown to be prevented when NOS activity was blocked.  Therefore, 
NO might act either downstream for cAMP/PKA or both messengers are required for 
LTP.  However, the latter possibility is less likely given that the NO donor NONOate was 
capable of inducing LTP even in the presence of PKA blockade.  This suggests that 
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cAMP/PKA stimulates NO production.  Although NOS has several phosphorylation sites 
that are recognized by kinases (Bredt et al.; 1992), including PKA and PKC (Okada 
1995), direct evidence of PKA modification of NOS activity is limited (Inada et al.; 1998, 
1999) and controversial (Brune & Lapetina 1991; Bredt et al.; 1992).  PKA could 
modulate the Ca2+ sensitivity of NOS (Okada 1995) or stimulate NO production through 
an indirect mechanism (Polte & Schroder 1998; Dubey et al.; 1998).  cAMP-dependent 
NO production might provide a mechanism for short-term enhancement of transmitter 
release, but additional cAMP-dependent mechanism might be necessary to consolidate 
longer-term potentiation.  Additionally, it has been reported that the expression of LTP is 
not due to a sustained elevation of NO production, but due to a relatively transient 
increase.  Consistent with the proposed presynaptic origin of LTP and postsynaptic 
location of guanylate cyclase (Ariano et al.; 1982), it has been reported that LTP was not 
sensitive to inhibition of either extracellular or intracellular guanylate cyclase or to 
inhibition of PKG.  This would suggest that the actions of NO in mediating potentiation, 
do not take place via cGMP or PKG. 
 Cerebellar LTP at Inhibitory Synapses.  In cerebellar Purkinje neurons, the 
activation of an excitatory synaptic input can induce a long-lasting potentiation of 
GABA-mediated inhibitory synaptic currents, a phenomenon called rebound potentiation.  
Similar to LTP in the CA1 area of the hippocampus, a rise in intracellular Ca2+ is an 
important step for triggering rebound potentiation.  The addition of Ca2+ chelators was 
found to block the induction of rebound potentiation (Kano et al.; 1996).  The elevation 
of intracellular Ca2+ concentration is believed to be transient (Kano et al.; 1992) and due 
to the activation of VDCCs (Llano et al.; 1991; Vincent et al. 1992) and postsynaptic 
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internal Ca2+ stores (Kano et al.; 1996).  However, the intracellular mechanisms linking 
the short-lived Ca2+ to the much longer lasting rebound potentiation are unclear. 
 Cerebellar LTD.  The induction of LTD is postsynaptic and requires a rise in 
intracellular Ca2+.  Early in vivo experiments suggest that the flow of Ca2+ through 
VDCCs was involved because hyperpolarization evoked by the activation of stellate cell 
prevented the occurrence of LTD (Ekerot et al., 1985).  In more recent in vitro 
experiments, it was shown that LTD of synaptic transmission at PF-PC synapses can be 
induced by conjunctive stimulation of PFs and climbing fibers (CFs) impinging the same 
PC (Sakurai 1987).  Moreover, this long term change in synaptic efficacy no longer 
occurred when intracellular Ca2+ in PCs was buffered by EGTA, a Ca2+ chelator (Sakurai 
1990).  The crucial role of the rise of Ca2+ resulting from the activation of VDCC in LTD 
induction was further demonstrate that LTD of PF-mediated responses is consistently 
induced by pairing these synaptic responses with Ca2+  spikes directly induced in the 
postsynaptic cell by depolarizing pulse (Crépel & Jaillard 1991; Blond et al.; 1997).  The 
flow of Ca2+ into PCs through VDCCs in the induction of LTD was confirmed more 
recently by two independent groups.  Linden and coworkers (1991) demonstrated that 
LTD of AMPA-mediated currents is induced by conjunctive iontophoretic glutamate 
pulses.  Additionally, PC depolarization was sufficient to produce Ca2+ entry through 
VDCCs.  Konnerth et al.; (1992) showed that a transient rise in internal Ca2+ is sufficient 
to induce LTD.  It must be emphasized that Ca2+ concentration levels return to normal 
after LTD induction, ruling out the possibility that this form of synaptic plasticity is 
merely a pathological process. 
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 Although Ca2+ has been shown to play a crucial role in the cerebellum, the 
physiological significance of Ca2+ release from internal stores is still a matter of debate.  
Evidence has shown that ryanodine and ruthenium red, two inhibitors of ryanodine 
receptors, block the induction of LTD (Kohda et al.; 1995).  In addition, it has been 
reported that dialysis with heparin, an inhibitor of InsP3-sensitive internal stores inhibited 
LTD induction (Kasono & Hirano 1995).  Moreover, depletion of ryanodine- and InsP3-
sensitive stores by thapsigargin, a compound which irreversibly depletes Ca2+ internal 
stores, blocked LTD induction (Hemart et al. 1995).  However, all these compounds have 
several reported non-specific effects (Michelangeli et al.; 1994; Ehrlich et al.; 1994).  
Therefore, demonstration of the need for Ca2+ release from internal stores in LTD 
induction might be more or less compelling depending on the protocol used to induce 
LTD. 
 Cerebellar PCs, in marked contrast to most other neurons in the brain, do not bear 
functional NMDA receptors postsynaptically (Crépel et al.; 1982; Dupont et al.; 1987; 
Audinat et al.; 1990; Krupa & Crépel 1990; Konnerth et al.; 1990; Llano et al.; 1991; 
Farrant & Cull-Candy, 1991; Lachamp et al.; 2005; Metzer et al.; 2005).  Thus, fast 
excitatory synaptic transmission at PF-PC synapses is mediated entirely by non-NMDA 
ionotropic receptors, namely AMPA.  In addition, it has now been well established that 
PF-PC synapses also bear mGluR1, which is positively coupled to phospholipase C, 
activation of which leads to the production of inositol 1,4,5-triphosphate (InsP3) and 
diacylglycerol (DAG) (Martin et al. 1992). 
 In dissociated PC cultures, it was demonstrated both AMPA and mGluRs must be 
activated to induce LTD (Linden et al.; 1991; Shigemoto et al.; 1994).  The addition of 6-
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cyano-7-nitroxaline-2-3-dione (CNQX), AMPA antagonist, prevented the induction of 
LTD.  However, application of CNQX after the induction of LTD did not prevent its 
maintenance (Hemart et al.; 1995).  Therefore, the induction of LTD of PF-mediated 
responses requires the activation of both of these receptors. 
    11.  Statement of Work 
 The scope of the work in the following chapters investigates the effects of PREGS 
on vestibulo-ocular reflex adaptive changes in vivo.  The data presented in these chapters 
illustrated that inhibition of the GABAA and/or activation of the NMDA receptors, by 
PREGS, enhances the acquisition (learning) phase of adaptive VOR gain increases, but 
not gain decreases.  These results support the hypothesis that there are pharmacologically 
separate and distinct mechanisms involved in adaptive VOR gain increases and 
decreases.  In addition, the effect of PREGS on the retention (memory) phase of the 
adapted vestibulo-ocular reflex gain change was also investigated.  The results of these 
experiments illustrates that the role of the cerebellum may change after acquisition and 
that the site of retention adaptation may be external to the cerebellum. 
Experiment 1: Investigate the effects of a neurosteroid, pregnenolone sulfate 
on the acquisition phase of VOR adaptation. 
Hypothesis:  PREGS’ antagonistic action on the GABAA, AMPA/KA 
receptors and/or agonist action on the NMDA would enhance 
adaptive VOR gain increases and decreases. 
Experiment 2: Determine whether pregnenolone sulfate could actively reverse
 adaptive VOR gain decreases. 
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Hypothesis:  PREGS’ antagonistic action on the GABAA, AMPA/KA 
receptors and/or agonist action on the NMDA would actively
 reverse adaptive VOR gain decreases. 
Experiment 3: Investigate the effects of a neurosteroid, pregnenolone sulfate 
on the retention phase of VOR adaptation. 
Hypothesis:  PREGS’ agonist action on the NMDA receptors would enhance
 the retention of adaptive VOR gain increases. 
Experiment 4: Determine if the enzymatic mechanisms involved in the
 formation of pregnenolone was evolutionarily conserved. 
Hypothesis:  Cytochrome P-450 side chain cleavage enzyme will be
 dectected and localized in the cerebellum, specifically in
 cerebellar Purkinje cells. 
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CHAPTER 2: METHODS AND MATERIALS 
Subjects and Initial Set Up Procedures 
 Goldfish (Carassius auratus) overall length 15-20 cm, acquired from Hunting 
Creek Fisheries (Thurmont, MD) were housed in 35-55 gallon laboratory aquariums 
which were maintained at 19˚C.  The aquarium water was dechlorinated (Genesis®, 
Aquarium Products; Glen Burnie, Md) and treated to maintain electrolyte balance (Start 
Right®, Jungle Laboratories, Corp.; Cibolo, Texas).  All animals were fed daily, 
maintained on a 12-hour light-dark cycle, and acclimated to the aquariums for 
approximately 1-2 weeks prior to use. 
 In each experiment, a goldfish was carefully fitted on a respiration tube to ensure 
a constant flow of aerated water over the gills.  They were secured between a set of 
sponges and Plexiglas body restraints within a white cylindrical test aquarium (28 cm 
diameter; 17.5 cm height).  Lidocaine (2% gel) was applied around the mouth of the 
goldfish prior to securing the mouth to the respiration tube.  Water level in the test 
aquarium was kept 1 cm above the top of the eye to ensure proper vision.  The water 
temperature in the test aquarium was maintained at 19˚C ± 0.1˚C by a thermopile heat 
exchanger (Biomedical Engineering, Thornwood, NY). 
 Prior to adaptive VOR training, a head block was constructed to stabilize the head 
in order to avoid any damage to the cerebellum (Figure 2.1).  During this surgery the 
animals were anesthetized (MS222: 1:2000) while the head block made of dental cement 
was attached to the anterior part of the cranium.  This surgery was performed 1 to 4 days 
prior to adaptive VOR experiments.  In general, head blocks remained in place for up to 
two weeks before becoming detached. 
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Figure 2.1. Head-block Construction 
A)  Four self tapping screws were screwed into the skull bone of goldfish; two anteriorly 
and two posteriorly.  B)  A brass restraining bar with two holes was used to separate 
stainless steel machine screws that were key to securing goldfish head.  The midline of 
this brass restraining bar was slotted so that it could be adjusted according to the size of 
the goldfish.  C)  The machine screws were set in place so that the heads rested between 
the four previously attached self tapping screws, but did not push down on the goldfish’s 
head.  D)  Dental acrylic was used to completely embed the heads of the machine screws 
and a smooth mound was created. 
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 In each experimental, an animal was placed in the test aquarium as described 
before and restrained via the head block.  Lidocaine (2% gel) was applied to both eyes.  
Multi-turn eye coils (80 turns; 1.8 mm diameter; Type B; Sokymat, Granges, 
Switzerland) were surgically attached with ophthamalic suture (6-0 coated Vycril®; 
Ethico J-570G) to each eye (Figure 2.2).  Movements of the eyes were measured by the 
electromagnetic detection technique with equipment purchased from Remmel Labs 
(EM4, Ashland, MA).  After application of lidocaine (2% gel) to the top of the head, a 
craniotomy was performed above the cerebellum using a #11 scalpel blade.  The 
underlying fat cells were gently removed by aspiration, exposing the dorsal surface of the 
cerebellum.  A probe holder was attached to the test aquarium and a small piece of gauze 
soaked in artificial cerebral spinal fluid (CSF) was placed over the opening of the 
cerebellum.  At the completion of these procedures, the cylindrical test aquarium was 
affixed to the vestibular table so that the head of the goldfish was located at the center of 
vertical axis rotation.  Pregnenolone sulfate sodium-potassium salt (Sigma P-162) was 
prepared in a solution of artificial CSF.  The artificial CSF (for fresh-water fish) consists 
of 100.00 NaHCO3, 2.49 KCL, 1.00 MgCl6·H2O, 0.44 NaH2PO4·H2O, 1.13 CaCl2·H2O 
and 5.00 NaHCO3 (in mM; final pH = 7.2).  For acquisition experiments PREGS (approx. 
pH 6.5) or artificial cerebral spinal fluid (CSF-control) was microdialyzed into the 
cerebellum using a microperfusion pump at a rate of 1µL/min for four hours (See 
Methods Microdialysis Procedures) or microinjected using a microperfusion pump at a 
rate of 0.05µL/min for 10 minutes (See Methods Microinjection Procedures). 
  
39 
 
 
 
 
 
Figure 2.2. Eye Movement Measurements 
Multi-turn ocular search coils were surgically attached to each eye above the pupil in 
order to measure eye movements.  The suture was threaded through the center of the eye 
coil.  The suture was then threaded through the holes of a hand-made plastic eye button, 
positioned and secured to the eye coil.  Care was taken that the eye coil did not obscure 
vision or impede on movement of the eye. 
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Experimental Equipment and Behavioral Procedures 
 VESTIBULAR AND VISUAL APPARATUS.  The vestibular table, was driven 
by a position and velocity feedback servo-controlled motor (Inland Motor, Radford, VA) 
located in a separate experimental room.  The electromagnetic field generating coils and 
cylindrical test aquarium were mounted on this table.  A planetarium (Biomedical 
Engineering, Thornwood, NY) controlled by a second servomotor was placed directly 
over the goldfish’s head.  This planetarium displayed a random dot stimulus pattern of 
light on the inside surface of the cylindrical test aquarium.  Goldfish follow whole field 
visual targets for an extended period of time with no diminution of the response during 
visulo-vestibular stimulation. 
PROCEDURES.  The vestibulo-ocular reflex operates in conjunction with the 
visual system to produce compensatory eye movements during head motion.  During 
rapid head movements, the visual-oculomotor system alone is not fast enough and is 
complemented by the more rapid vestibulo-ocular motor system.  Since both vestibular 
and visual inputs are working together, the reflex is more appropriately called the visuo-
vestibulo-ocular reflex (Vis-VOR).  In experimental studies of the vestibulo-ocular reflex 
(VOR) carried out in the dark, the reflex is operating solely on information from the 
vestibular system.  The gain of the reflex is the magnitude (position) or the rate (velocity) 
of eye movement compared to that of the head (vestibular table).  Phase refers to the 
timing of the eye and head (vestibular table) movement with respect to each other.  
Typically, in normal operation, when one is viewing an earth fixed visual object the gain 
of Vis-VOR is equal to one (1X).  To produce Vis-VOR (1X) experimentally, the visual 
stimulus of the planetarium was held in an earth fixed position during sinusoidal table 
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rotation (⅛ Hz at 20˚; maximum velocity = 15.7˚/s).  In-phase sinusoidal rotation of the 
table and planetarium together produced suppression of Vis-VOR gain in this study (Vis-
VOR (0X)).  Augmentation of Vis-VOR gain was created by rotating the planetarium 
rotating at double the amplitude of the vestibular table (⅛Hz at ±40˚; maximum velocity 
=31.4 ˚/s) and 180˚ out of phase with the table (⅛ Hz at 20˚; maximum velocity = 
15.7˚/s).  The gain condition is approximately three times that of normal (Vis-VOR 
(3X)).  These testing and training conditions have been used in previous studies of VOR 
adaptation (Li et al.; 1995; McElligott et al.; 1998). 
EYE MOVEMENT MEASUREMENTS.  Calibrations were performed with eye 
coils surgically attached to the eyes of the fish.  In the beginning of each experiment, 
calibrations for each goldfish were performed before and after modification of the Vis-
VOR and VOR during two separate 50 second intervals.  Gains of the reflex were 
determined in the following gain conditions: (1) Vis-VOR (1X), (2) VOR, (3) suppressed 
Vis-VOR (0X) and (4) augmented Vis-VOR (3X) 
 After these initial measurements of the reflex gain, adapted gain increases and 
decreases were produced over a three hour period.  Animals were tested for adaptive gain 
changes every 30 minutes for the 3 hours of adaptation.  At the end of the acquisition 
phase (training), a final set of measurements was performed for the same test conditions 
that were used prior to adaptation. 
Data Analysis 
 SINUSOIDAL STIMULATION.  For determination of reflex gain, signals from 
the vestibular table, planetarium,  and right and left horizontal eye position were 
individually amplified and recorded.  Each of the signals was collected (at 50 samples/ 
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per channel/sec during a 50-sec test period) and analyzed on a Macintosh computer with 
the use of LabVIEW® (National Instruments).  This computer program removed the fast 
phases (saccades and eye blinks) and reconstructed the position signals for the remaining 
slow phase eye movements.  Gain was determined by a comparison of the Fast Fourier 
Transform (FFT) of vestibular table and eye position signals.  Gain is defined as the ratio 
of the amplitude of the eye to head movement for the fundamental frequency (⅛ Hz) at 
which the animals were tested.  The gain was determined by subjecting the ray eye and 
head signals to FFT analysis after the fast phase (saccades) eye movements were 
removed from the eye signals.  For each condition that was tested, the gain was 
determined by averaging two separate data samples of 50 s each.  The individual gains 
for the right and the left eye were averaged together to obtain a single measure of reflex 
gain to compensate for any bias that may be introduced by the infusion.  These analysis 
procedures were originally described by Barlow & Freedman (1980) and adopted for use 
in the cat (McElligott & Freedman 1988) and goldfish (Li et al.; 1995; McElligott et al.; 
1995, 1998). 
Microdialysis Procedures 
 After initial vestibulo-ocular reflex calibrations, PREGS or a control agent 
(artificial fresh-water fish cerebral spinal fluid (CSF-control)) was infused into the 
vestibulo-cerebellum via a microdialysis probe inserted approximately 2.5 mm into the 
caudal-dorsal surface of the vestibulo-cerebellum centered with respect to the midsagittal 
plane (Fig 2.3A).  Probe placement in the cerebellum was verified by microdialyzing 1% 
Toluidine blue dye (Fig. 2.3B). 
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 The microdialysis technique allows for a longer application of drug.  Probes were 
constructed in a manner similar to that previously described (Parry et al.; 1990), (176 µm 
diameter; 2.5 mm length).  After the first calibration of vestibulo-ocular reflex, the 
dialysis probe was inserted and the goldfish was rotated at a Vis-VOR gain 1X for one 
hour in order to minimize disruption of the vestibulo-cerebellum.  Commencing one hour 
before the initiation of reflex adaptation, PREGS or CSF-control was delivered.  During 
this period the goldfish was placed back at the Vis-VOR gain condition (1X).  A final set 
of calibrations was taken just before the start of adaptation and at the end of adaptation.  
PREGS or CSF- control was continuously delivered for the three hour training period.  
Similar methods were used in previous studies of VOR adaptation (Li et al.; 1995; 
McElligott et al.; 1995, 1998). 
Microinjection Procedures (Acquisition) 
 Microinjection application was used to test the immediate effect of PREGS 
application on acquisition phase of adaptation (learning).  After initial VOR calibrations, 
a bilateral injection probe consisting of two fused silica tubes (separated by 1 mm) was 
centered above the caudal aspect of the goldfish cerebellum.  The fused silica tubes, were 
inserted to a depth of approximately 2.5 mm into the vestibulo-cerebellum at the midline 
(Fig. 2.4A & B).  Solutions were injected using a microperfusion pump at rate 
0.05µL/min for 10 minutes, (bilateral total volume =1 µL).  Microinjection probes were 
inserted at least 30 minutes prior to the initiation of adaptation to minimize disruption to 
the vestibulo-cerebellum as well as to the performance and adaptation of the VOR.  After 
secondary calibrations were performed PREGS or CSF-control was injected into the 
cerebellum.  During these periods the goldfish was placed back at the Vis-VOR gain  
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Figure 2.3. Microdialysis Probe and Probe Placement in Cerebellum. 
A) Sagittal section of a goldfish brain illustrating the location of a microdialysis probe in 
the vestibulo-cerebellum.  Only the dialysis membrane (dia = 176µM) of the probe was 
inserted into the tissue.  From caudal to rostral, the structures identified are, the vagal 
lobe (VL), the cerebellum (CB) and the valvula cerebelli (VC).  B) Sagittal section of a 
goldfish brain illustrating the proper placement of the microdialysis probe in the 
vestibulo-cerebellum.  Bar represents 1mm 
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Figure 2.4. Microinjection Probe and Probe Placement in the Cerebellum 
A) Sagittal section of a goldfish brain illustrating the location of a bilateral microinjection 
probe in the vestibulo-cerebellum.  From caudal to rostral, the structures identified are, 
the vagal lobe (VL), the cerebellum (CB) and the valvula cerebelli (VC).  B) Top view of 
a goldfish brain, the two dark circles indicate the position of the where the probe was 
inserted.  C) Sagittal section of a goldfish brain illustrating the proper placement of the 
microinjection probe in the vestibulo-cerebellum. 
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condition (1X).  Calibrations were taken 5 minutes after PREGS or CSF-control agent 
was delivered.  Afterwards, the animals were trained to either increase or decrease their 
VOR for 3 hours.  At the end of 3 hours of adaptive training, a final full calibration was 
performed.  Probe placement in the cerebellum was verified by microinjecting 1% 
Toluidine blue dye (Fig. 2.4C.). 
Microinjection Procedures (Retention) 
 Microinjection application was used to test the effect of PREGS application on 
retention (memory) phase of VOR adaptation.  Similar procedures were used as described 
above (Methods Microinjection Procedures Acquisition).  In the first set of retention 
experiments, after secondary calibrations were performed, the PREGS or CSF-control, 
were injected into the cerebellum.  During these periods the goldfish was rotated at the 
Vis-VOR gain condition (1X).  A final set of calibrations was taken 5 minutes after 
PREGS or CSF-control agent was injected.  A 3 hour adaptive training period followed.  
At the end of 3 hours another full series of Vis-VOR and VOR measurements were 
performed.  Upon completion of 3 hour adaptive training period the animals were 
allowed to rest in the light with no vestibular stimulation.  The animals were tested post-
adaptive VOR gain every 15 minutes for the first hour and every 30 minutes for the 
remaining two hours.  At the end of 3 hours a final full calibration was performed.  In the 
second set of retention experiments after the Vis-VOR and VOR performance 
measurements were carried out, the adaptive training period commenced.  At the end of 
the 3 hour training period final Vis-VOR and VOR measurements were taken.  CSF-
control or PREGS was then injected into the vestibulo-cerebellum of the goldfish.  The 
animals were kept in the adaptive training condition during the injection.  Upon 
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completion of injection, the animals remained at rest in the light with no vestibular 
stimulation.  The animals were tested for post-adaptive VOR gain every 15 minutes for 
the first hour and every 30 minutes for the remaining two hours.  At the end of 3 hours a 
final full set of measurements was performed. 
Histology 
 After the completion of the experiment several of the goldfish were deeply 
anesthetized with ethyl-3-aminobenzoate methanesulfonate salt (MS222) and whole 
brains were quickly removed and frozen on dry ice.  These brains had been previously 
injected with 1% toluidine blue dye to identify the site of probe placement.  These brains 
were cut on a cryostat at 20 µm at -22°C and then mounted on superfrost glass slides.  It 
can be seen (Fig 2.3B & 2.4C) that infusion of the drug was restricted to the cerebellum 
and did not invade the surrounding tissue. 
Immunohistochemical analysis with cytochrome P-450scc antibody 
 In the present immunohistochemical experiment, a female  goldfish, Carassius 
auratus, in the pre-breeding phase (February 2006) was deeply anesthetized with ethyl 3-
aminobenzoate methanesulfonate salt (MS-222; Sigma) and then perfused transcardially 
with 0.1M PB followed by fixative solution (4% paraformaldehyde in 0.1M PB).  The 
animal was then sacrificed and the brain removed.  The brain was post-fixed in the same 
fixative solution overnight at 4°C and then soaked in a refrigerated sucrose solution (20% 
sucrose) until brain sank.  Brain was cut sagittally at 20-µm thickness with a cryostat at -
22°C. 
 The sections were processed according to the routine avidin-biotin-peroxidase 
complex immunohistochemical technique.  Quenching of endogenous peroxidase activity 
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from sections was accomplished by incubation with 3% H2O2 in absolute methanol.  
After blocking non-specific binding components with the diluted normal blocking serum, 
sections were incubated with primary antiserum (Rabbit anti-rat cytochrome P450scc 
polyclonal; 1:200 dilution; Chemicon) in buffer for 30 minutes at room temperature.  The 
primary immunoreaction was followed by a 30 minute incubation with diluted 
biotinylated secondary antibody solution and finally by a 30 minute incubation with the 
avidin-biotin complex (Vectastain ABC Elite kit, Vector Laboratories, Inc.) all at room 
temperature.  Immunoreactive products were detected by immersing the sections for 2-5 
minutes in a diaminobenzidine (DAB) solution.  The localization of immunoreactive cells 
in the fish brain was studied using a Nikon Eclipse TE300 microscope. 
GSI Sample Collection 
 From April 2003 to February 2006, sampling of gonads was conducted on female 
fish.  Since fish obtained consisted of more females than males, these samplings were 
done only on females.  The average body weight (BW) was 93 ± 1.43 g (mean ± SEM).  
At the end of every experiment the gonads were removed and weighted for calculation of 
gonadosomatic index (GSI; gonad weight X 100/BW). 
 Based on the seasonal changes, the reproductive cycle was separated into five 
periods using the classification of Munkittrick & Leatherland (1984): 
• 1.  October to March was termed the “preparatory period” (PRE) 
• 2.  April and May was termed the “low spawning period” (LP) 
• 3.  June to August was termed the “high spawning period” (HP) or “secondary 
spawning period” (SSP) 
• 4.  September was termed the “post-spawning period” (POST) 
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Statistics 
 The first stage of my statistical analysis was to determine the degree to which, if 
at all, the data departed from normality.  The statistical analysis used to make these 
calculations was a Kolmogorov-Smirnov (KS) test.  This statistical analysis was 
performed using the statistical analysis software package known as Statview on a 
Macintosh computer.  The KS test tests whether the distribution of a continuous 
variable is the same for two groups.  The null hypothesis is that the two distributions 
are the same under the assumption that the observations from the two distributions are 
independent of each other.  The KS test is calculated by comparing the two 
distributions at a number of points and then considering the maximum difference 
between the two distributions.  To carry out this calculation, the mean and standard 
deviation of the observations were first calculated.  The sample mean was then 
subtracted from each group and divided by the standard deviation, which converts the 
original measurements to those of the standard normal distributions.  The observed 
and expected values were then compared.  Only one comparison was done for these 
statistical analyses, each concentration of PREGS was compared to CSF-control.  
There were no comparisons made between the different concentrations of PREGS 
with each other.  Afterwards a results table containing the degrees of freedom, the 
number observation in each group, the maximum difference between the groups, the 
Chi-square statistic and p-value was displayed. 
 The data presented in this thesis was not normally distributed and therefore 
parametric statistics could not be used to analyze the data present in this work.  
Therefore, the non-parametric equivalent of the analysis of variance (ANOVA), 
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Kruskal-Wallis was performed.  Significance was found and then multiple KS tests 
were performed.  Multiple KS tests were performed using the Bonferroni correction, 
in which the target p-value for significance testing, 0.05, was divided by the number 
of comparisions.  The null hypothesis was rejected (e.g. considerable deviations from 
a normal distribution) if below the new target p-value. 
 The numbers of animals (n) used in these experiments are low due to the 
experimental design which reduces the variance in my data collection (Methods 
Experimental Equipment and Behavioral Procedures).  Published worked from our 
laboratory and many others in this field have small sample and therefore large 
samples groups are not need for me to be confident that the statistical significance 
presented here are correct.  Group data was reported as mean ± SE. 
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CHAPTER 3: THE EFFECTS OF PREGNENOLONE SUFLATE ON THE 
ACQUISITION PHASE OF VESTIBULO-OCULAR REFLEX ADAPTATION 
 
A.  Introduction 
 The VOR has served as an ideal model for the study of sensori-motor integration 
in the central nervous system (CNS).  Adaptation of the reflex has also provided us with a 
neuroplastic model for the investigation of information acquisition (learning) and 
retention (memory) involved in the CNS (du Lac et al.; 1995).  The VOR stabilizes visual 
targets on the center of an animal’s visual field in order to maintain clear vision during 
head movements by coordinating equal, but opposite eye movements with respect to the 
head.  Adaptation of the VOR occurs when there is a mismatch of the vestibular and 
visual stimuli.  This results in a progressive change in the VOR gain leading to the 
maintenance of visual clarity.  Changes during development, aging or injury require that 
the VOR be modifiable in order for visual clarity to be maintained. 
 Investigations in locating the neuronal site(s) responsible for the behavioral 
adaptation of the VOR have implicated two CNS areas; the cerebellum and the vestibular 
nuclei complex in the brain stem (Lisberger, 1994b; du Lac et al.; 1995).  Over the past 
decades, studies have shown that the cerebellum is the neuronal site where neuroplastic 
changes occur that are responsible for VOR gain adaptation (Robinson, 1974; Robinson, 
1976; Michnovicz and Bennett, 1987; Pastor et al., 1994; McElligott et al.; 1998).  There 
are also a number of studies that support the view that such changes occur external to the 
cerebellum, most notably in the vestibular nucleus complex (Cohen et al.; 1992; Miles 
and Lisberger, 1981a).  In the cerebellum, the horizontal VOR neuronal circuitry utilizes 
both positive and negative feedback systems via a three-neuron arc and the cerebellar 
circuit.  Stimulation of the horizontal semicircular canals on either side of the head sends 
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neural signals via primary vestibular nerve fibers to the relay cells of the VOR located in 
the vestibular nucleus.  Collaborative influence of afferent signals from both the climbing 
fibers and mossy fibers modulates cerebellar Purkinje cells (PC) that in turn send 
neuronal signals to the vestibular nucleus.  These vestibular cells then send either 
excitatory or inhibitory signals to the motor neurons in the abducens and oculomotor 
nuclei.  The result is that both eyes move in a direction opposite to that of the head 
rotation and correct the effects of head rotation thus stabilizing images on the fovea of the 
retina.  The main feature of this vestibulo-cerebellar pathway is that cerebellar PCs 
project monosynaptic inhibitory (GABA) influences onto vestibular neurons in the 
brainstem (Voogd & Glickstein, 1998; Ghelarducci et al.; 1975; Simpson & Alley, 1974). 
 Our investigations have focused on the pharmacological aspects of this 
adaptation.  Previous studies from our laboratory have demonstrated that direct 
administration of D-2-amino-5-phosphonopentanoic acid (D-AP5), NMDA antagonist, 
by local pressure injection into the vestibulo-cerebellum of the goldfish inhibits the 
acquisition phase of adaptive VOR gain increases, but not gain decreases.  In addition, 
direct administration of muscimol, a GABAA agonist, by microdialysis into the vestibulo-
cerebellum of the goldfish inhibited the acquisition phase of both adaptive VOR gain 
increases and decreases.  Recent studies from our laboratory have also demonstrated that 
microdialysis of estradiol into the vestibulo-cerebellum enhances adaptive gain increases, 
but not adaptive gain decreases.  The results presented here show that pregnenolone 
sulfate (PREGS), a GABAA antagonist and a NMDA agonist, enhances adaptive gain 
increases, but not gain decreases in the acquisition phase of VOR adaptation.  The results 
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of this study support and confirm that there are separate and distinct pharmacological 
mechanisms involved with adaptive gain increases and decreases. 
B.  Results 
    1.  Normal Vis-VOR and VOR Gain Before and After Cerebellar Control and Drug 
Infusion (Microdialysis) 
 Increase Adaptation.  Normal gains for Vis-VOR (1X and 3X) and VOR were 
measured in 2 different conditions prior to adaptation (Table 3.1).  For CSF-control 
animals, (n=8) normal initial Vis-VOR gain at the 1X and 3X gain condition was 0.99 ± 
0.02 and 1.34 ± 0.05, respectively, the VOR gain was 0.79 ± 0.02 (Control, post-
insertion, Table 3.1).  Goldfish (n=5) that were microdialyized with PREGS (10µM), had 
comparable gains for these different stimulus conditions 0.99 ± 0.01 (1X), 1.47 ± 0.18 
(3X) and 0.77 ± 0.12 (VOR), respectively (PREGS, post-insertion, Table 3.1). 
 Decrease Adaptation.  In a similar manner, the normal gain for Vis-VOR (1X and 
0X) and VOR of goldfish that underwent adaptive gain decreases were also measured 
(Table 3.2).  For CSF-control animals, (n=6) normal initial Vis-VOR gain at the 1X and 
0X gain condition was 1.02 ± 0.02 and 0.34 ± 0.07, respectively; the VOR gain was for 
these animals was 0.85 ± 0.03 (Control, post-insertion, Table 3.2).  The animals that were 
microdialyzed with PREGS (n=5; 10µM), had comparable gains for these different 
stimulus conditions 1.03 ± 0.02 (1X), 0.46 ± 0.11 (0X) and 0.89 ± 0.04 (VOR), 
respectively (PREGS, post-insertion, Table 3.2).  There appears to be no change in the 
normal Vis-VOR or VOR gain induced by probe insertion or drug infusion into the 
cerebellum prior to VOR adaptation for both gain increases and decreases. 
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    2.  Normal Vis-VOR and VOR Gain Before and After Cerebellar Control and Drug 
Infusion (Microinjection)) 
 Increase Adaptation.  Normal gains for Vis-VOR (1X and 3X) and VOR were 
measured in 2 different conditions prior to adaptation (Table 3.3).  For CSF-control 
animals, (n=7) normal initial Vis-VOR gain at the 1X and 3X gain condition was 0.99 ± 
0.02 and 1.16 ± 0.06, respectively, the VOR gain was 0.83 ± 0.05 (Control, post-
insertion, Table 3.3).  Goldfish (n=6) that were microinjected with PREGS (100µM) had 
initial Vis-VOR gain at the 1X and 3X gain condition 1.08 ± 0.05 and 1.31 ± 0.08, 
respectively, the VOR gain was 0.89 ± 0.06 (PREGS, post-insertion, Table 3.3).. 
 Decrease Adaptation.  In a similar manner, the normal gain for Vis-VOR (1X and 
0X) and VOR of goldfish that were to undergo adaptive gain decreases were also 
measured (Table 3.4).  For CSF-control animals, (n=6) normal initial Vis-VOR gain at 
the 1X and 0X gain condition was 1.05 ± 0.04 and 0.24 ± 0.03, respectively, the VOR 
gain was 0.89 ± 0.06 (Control, post-insertion, Table 3.4).  The animals that were 
microinjected with PREGS (n=6; 100µM) had normal initial Vis-VOR gain at 1X and 0X 
gain condition, respectively, the VOR gain was 1.07 ± 0.04 and 0.23 ±  0.03, 
respectively, the VOR gain was 0.89 ±  0.04 (PREGS, post-insertion, Table 3.4).  The 
insertion of the probe or microinjection into the cerebellum prior to VOR adaptation does 
not appear to induce any Vis-VOR or VOR gain changes for both gain increases and 
decreases. 
    3.  Effect of PREGS on Adaptive Vis-VOR and VOR Gain Increases (Microdialysis) 
 The five concentrations of PREGS (0.1, 1, 10, 100, 1000 µM) that were used in 
our studies had no effect on Vis-VOR or VOR gain performance prior to adaptation.  
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After 3 hours of adaptive training to increase reflex gain, CSF-control animals (n=8) 
produced final Vis-VOR gain of 2.34 ± 0.14 resulting in a gain change of 80%.  In 
comparison, animals receiving 10µM of PREGS produced Vis-VOR gain increases (2.90 
± 0.26; 103%; NP; Kolmogorov-Smirnov (KS) test; p<0.036; Fig 3.4B). 
 The effect of the PREGS concentrations was also tested on the VOR.  
Interestingly, only the intermediate concentrations (1 & 10 µM) enhanced adaptive VOR 
gain increases compared to the CSF-control animals after the 3 hour adaptation period.  
The most significant gain increase above baseline in comparison to CSF-controls was 
seen in animals receiving 10µM of PREGS.  This is illustrated by comparing the 
individual VOR eye movements recorded from a goldfish that received PREGS with that 
of a goldfish that received CSF-control before (0 hours) and after 3 hours of adaptive 
training (Fig 3.3).  The PREGS dialyzed goldfish produced a gain increase from 0.82 to 
2.24 (a final VOR adaptive gain increase of 152%), whereas the CSF-control dialyzed 
goldfish produced a gain increase from 0.80 to 1.55 (a final VOR adaptive gain increase 
of 94%). 
 Group data from five goldfish show that PREGS (10µM), when microdialyzed 
into the vestibulo-cerebellum, significantly enhanced (NP, Kolmogorov-Smirnov (KS) 
test; P<0.001) the acquisition of adapted VOR gain increases compared to CSF-control 
animals (n=8) during the 3 hour training period (Fig 3.4A).  After 3 hours of adaptive 
training to increase reflex gain, CSF-control animals produced final VOR gain of 1.42 ± 
0.08 resulting in a gain change of 71%.  In contrast, PREGS dialyzed animals produced 
significantly greater VOR (1.94 ± 0.17; 104%) gain increases. 
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Table 3.1.  Normal vestibulo-ocular reflex gain prior to adaptive training 
toward 3X (Microdialysis) 
 
 Condition Control (n=8) PREGS (n=5) 
Vis-VOR 1X post-insertion 0.99 ± 0.02 0.99 ± 0.01 
 post-infusion 1.00 ± 0.04 1.08 ± 0.03 
    
Vis-VOR 3X post-insertion 1.34 ± 0.05 1.47 ± 0.18 
 post-infusion 1.30 ± 0.05 1.43 ± 0.16 
    
VOR post-insertion 0.79 ± 0.02 0.77 ± 0.12 
 post-infusion 0.83 ± 0.05 0.95 ± 0.05 
Values are means ± SEM for the number of animals (n) 
 
 
Table 3.2.  Normal vesitbulo-ocular reflex gain prior to adaptive training 
toward 0X (Microdialysis) 
 
 Condition Control (n=6) PREGS (n=5) 
Vis-VOR 1X post-insertion 1.02 ± 0.02 1.03 ± 0.02 
 post-infusion 1.04 ± 0.04 1.08 ± 0.05 
    
Vis-VOR 0X post-insertion 0.34 ± 0.07 0.46 ± 0.11 
 post-infusion 0.36 ± 0.08 0.42 ± 0.10 
    
VOR post-insertion 0.85 ± 0.03 0.89 ± 0.04 
 post-infusion 0.88 ± 0.05 0.96 ± 0.05 
Values are means ± SEM for the number of animals (n) 
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Table 3.3.  Normal vestibulo-ocular reflex gain prior to adaptive training 
toward 3X (Microinjection) 
 
 Condition Control (n=7) PREGS (n=6) 
Vis-VOR 1X post-insertion 0.99 ± 0.02 1.08 ± 0.05 
 post-injection 0.99 ± 0.04 1.10 ± 0.04 
    
Vis-VOR 3X post-insertion 1.16 ± 0.06 1.31 ± 0.08 
 post-injection 1.23 ± 0.06 1.40 ± 0.09 
    
VOR post-insertion 0.83 ± 0.05 0.89 ± 0.06 
 post-injection 0.79 ± 0.05 0.96 ± 0.05 
Values are means ± SEM for the number of animals (n) 
 
 
Table 3.4.  Normal vestibulo-ocular reflex gain prior to adaptive training 
toward 0X (Microinjection) 
 
 Condition Control (n=6) PREGS (n=6) 
Vis-VOR 1X post-insertion 1.05 ± 0.04 1.07 ± 0.04 
 post-injection 1.13 ± 0.06 1.07 ± 0.04 
    
Vis-VOR 0X post-insertion 0.24 ± 0.03 0.23 ± 0.03 
 post-injection 0.23 ± 0.01 0.23 ± 0.03 
    
VOR post-insertion 0.89 ± 0.06 0.89 ± 0.04 
 post-injection 0.88 ± 0.07 0.94 ± 0.03 
Values are means ± SEM for the number of animals (n) 
 
 
 
  
58 
 The effect of various concentrations of PREGS on the acquisition phase of VOR 
adaptive gain increases is presented in Table 3.5.  These data demonstrate that the effect 
of PREGS on VOR adaptive gain increases reaches a plateau at the 10µM concentration.  
These data also demonstrate that after three hours of VOR adaptive training to a gain of 
3X, PREGS enhanced adaptive VOR gain increases at specific concentrations (1 & 
10µM). 
    4.  Effect of PREGS on Adaptive Vis-VOR and VOR Gain Decreases (Microdialysis) 
 This series of experiments, similar to those conducted for gain increases, involved 
adapted gain decreases of the VOR.  Contrary to the effect of PREGS on adaptive Vis-
VOR gain increases, adaptation of the Vis-VOR training to a gain of 0X over 3 hours 
appears not to have been affected by the local infusion of PREGS at 3 concentrations (1, 
10, & 100µM).  In comparison to CSF-control, PREGS microdialyzed animals did not 
appear to achieve a significant change in Vis-VOR gain over the 3 hours of adaptation. 
 The effect of PREGS concentrations was also tested on the VOR.  Interestingly, 
the animals achieving the most significant increase above baseline (10µM) found in VOR 
adaptive gain increases, did not appear to experience any drug induced enhancement 
compared to CSF-control animals after the 3 hour adaptation period.  This is illustrated 
by comparing the individual VOR eye movements recorded from a goldfish that received 
PREGS with that of a goldfish that received CSF-control before (0 hours) and after (3 
hours: Fig 3.5) adaptive training.  The PREGS dialyzed goldfish produced a gain 
decrease from 0.92 to 0.23 (a final VOR adaptive gain decrease of 75%) and the CSF-
control dialyzed goldfish produced a gain decrease from 0.87 to 0.13 (a final VOR 
adaptive gain decrease of 85%). 
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 Group data from 5 goldfish showed that PREGS, when administered into the 
vestibulo-cerebellum via microdialysis, did not appear to significantly enhance (NP 
Kolmogorov-Smirnov (KS) test; P<0.217, N.S.) the acquisition of adapted VOR gain 
decreases (Fig 3.6A) compared to CSF-control animals (n = 6).  After 3 hours of adaptive 
training to decrease reflex gain, CSF-control animals produced final VOR gain of 0.24 ± 
0.09 resulting in a gain change of 73%.  PREGS dialyzed animals produced final VOR 
gain of 0.28 ± 0.06 resulting in a gain change of71%. At no time during the adaptation 
period did the animals dialyzed with PREGS appear to produce a significant decrease in 
their overall VOR in comparison to the CSF-control animals. 
 The effect of drug concentrations on the acquisition phase of VOR adaptive gain 
decreases is presented in Table 3.6.  These data demonstrated the concentrations of 
PREGS that significantly enhanced adaptive VOR gain increases, did not have appear to 
have a marked effect on adaptive VOR gain decreases. 
    5.  Effect of PREGS on Adaptive Vis-VOR and VOR Gain Increases (Microinjection) 
 In this next series of experiments, the immediate effect of PREGS on the 
acquisition phase of the VOR adaptive gain increase was tested using a microinjection 
probe.  Prior to adaptation, all four concentrations of PREGS (1, 10, 100, 1000 µM) did 
not appear to have an effect on the initial Vis-VOR or VOR gain when microinjected into 
the vestibulo-cerebellum of goldfish.  Similar to microdialysis increase experiments, 
there was a significant effect of PREGS on adaptive Vis-VOR gain increases after the 3 
hour adaptation period compared to CSF-control group.  This enhancement was seen at 
several concentrations (10, 100, 1000 µM). 
 Group data from six goldfish show that 100 µM PREGS, when microinjected in 
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Figure 3.3. Individual Effect of PREGS on Adaptive VOR Gain Increases 
(Microdialysis). 
Comparison of raw eye movements (top trace in each data sample), eye velocity (middle 
trace) and reconstructed eye movements (lower trace; fast eye movement phases 
removed) of the VOR following infusion of CSF as a control or pregnenolone sulfate 
(10µM) into an individual goldfish.  These recordings were taken before (0 hours) and 
after (3 hours) VOR adaptive training to increase gain.  The number included with each 
data set is the reflex gain value for the reconstructed eye movements as determined by 
FFT analysis.  The pregnenolone sulfate fish produced a final adaptive VOR gain 
increase of 152%.  In comparison, the CSF-control fish produced a final VOR gain 
increases of 94%. 
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A     VOR 
 
 
 
B     Vis-VOR 
 
 
 
Figure 3.4. Effect of PREGS on Adaptive VOR and Vis-VOR Gain Increases 
(Microdialysis). 
Group data confirms that animals infused with pregnenolone sulfate (10µM, red 
triangles) produced greater VOR adapted gain increases after 3 hours of training 
compared to CSF-control animals (large squares).  After 3 hours of adaptive training, 
animals receiving pregnenolone sulfate increased their VOR gain by 104%.  In 
comparison, CSF-control animals only increased their VOR gain by 71% 
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Table 3.5.  Adapted increase VOR gains for various concentrations of PREGS vs. CSF-control 
 
 
Condition n 
Normal 
Post-Infusion 
Gain @ 0 hr 
 
Adapted 
Gain @ 1 hr 
 
Adapted 
Gain @ 2 hr 
 
Adapted 
Gain @ 3 hr 
Kolmogorov-
Smirnov 
P-value 
Control 8 0.83 ± 0.05 1.14 ± 0.07 1.30 ± 0.06 1.42 ± 0.08  
0.1µM 4 0.86 ± 0.03 1.09 ± 0.11 1.23 ± 0.13 1.35 ± 0.15 0.682 
1µM 3 0.90 ± 0.02 1.53 ± 0.21 1.77 ± 0.41 1.81 ± 0.19 0.001 
10µM 5 0.95 ± 0.05 1.34 ± 0.14 1.72 ± 0.18 1.94 ± 0.17 0.001 
100µM 12 0.84 ± 0.02 1.25 ± 0.08 1.48 ± 0.09 1.61 ± 0.08 0.030 
1000µM 5 0.90 ± 0.06 1.31 ± 0.08 1.58 ± 0.08 1.63 ± 0.10 0.029 
 
 
 Values for adapted gain are means ± SEM.  Multiple KS was performed using the Bonferroni correction.  The target p-
value for significance testing, 0.05 was divided by the number of comparisons, in this case 5.  The new target p-value was 
0.01.  Only the intermediate concentrations of PREGS, (1 & 10µM) exhibited a significant enhancement above baseline (NP; 
Kolmogorov-Smirnov (KS) test). 
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Figure 3.5. Individual Effect of PREGS on Adaptive VOR Gain Decreases 
(Microdialysis). 
Comparison of raw eye movements (top trace in each data sample), eye velocity (middle 
trace) and reconstructed eye movements (lower trace; fast eye movement phases 
removed) of the VOR following infusion of CSF as a control or pregnenolone sulfate 
(10µM) into an individual goldfish.  These recordings were taken before (0 hours) and 
after (3 hours) VOR adaptive training to increases gain.  The number included with each 
data set is the reflex gain value for the reconstructed eye movements as determined by 
FFT analysis.  The pregnenolone sulfate fish produced a final adaptive VOR gain 
decreases of 87%.  In comparison, the CSF-control fish produced a final VOR gain 
decreases of 83%. 
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A     VOR 
 
 
 
B     Vis-VOR 
 
 
 
Figure 3.6. Effects of PREGS on VOR and Vis-VOR Adaptive Gain Decreases 
(Microdialysis). 
Group data confirms that animals infused with pregnenolone sulfate (10µM, red 
triangles) did not produce greater VOR adapted gain decreases after 3 hours of training 
compared to CSF-control animals (large squares).  After 3 hours of adaptive training, 
animals receiving pregnenolone sulfate decreased their VOR gain by 71%.  In 
comparison, CSF-control animals decreased their VOR gain by 73%. 
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Table 3.6.  Adapted decrease VOR gains for various concentrations of PREGS vs. CSF-control 
 
Condition n 
Normal 
Post-Infusion 
Gain @ 0 hr 
 
Adapted 
Gain @ 1 hr 
 
Adapted 
Gain @ 2 hr 
 
Adapted 
Gain @ 3 hr 
Kolmogorov-
Smirnov test 
P-value 
Control 6 0.88 ± 0.05 0.46 ± 0.08 0.31 ± 0.08 0.24 ± 0.09  
1µM 5 0.86 ± 0.04 0.52 ± 0.07 0.35 ± 0.07 0.29 ± 0.07 0.122 
10µM 5 0.96 ± 0.05 0.52 ± 0.08 0.40 ± 0.06 0.28 ± 0.06 0.217 
100µM 5 0.91 ± 0.02 0.56 ± 0.08 0.36 ± 0.05 0.28 ± 0.06 0.333 
 
 
 Values for adapted gain are means ± SEM.  Multiple KS was performed using the Bonferroni correction.  The target p-
value for significance testing, 0.05 was divided by the number of comparisons, in this case 3.  The new target p-value was 
0.016.  There appears to be no enhancement of VOR gain decrease adaptation compared to control animals for any 
concentration of PREGS. 
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the vestibulo-cerebellum, significantly enhanced (NP Kolmogorov-Smirnov (KS) test; 
P<0.001) the acquisition of adapted Vis-VOR gain increases compared to CSF-control 
animals (n=7) during the 3 hour training period (Fig 3.8B).  After 3 hours of adaptive 
training to increase reflex gain, CSF-control animals produced final Vis-VOR gain of 
2.26 ± 0.08 resulting in a gain change of 84%.  In contrast, PREGS microinjected animals 
produced significantly greater Vis-VOR (2.84 ± 0.15; 102%) gain increases (Fig 3.8B). 
 The effect of PREGS concentrations was also tested on the VOR.  Goldfish (n=6) 
receiving 100 µM of PREGS experienced a significant increase above baseline for VOR 
training to a gain of 3X compared to CSF-controls (NP Kolmogorov-Smirnov (KS) test; 
P<0.001).  This is illustrated by comparing the individual VOR eye movements recorded 
from a goldfish that received PREGS with that of a goldfish that received CSF-control 
before (0 hours) and after (3 hours; Fig 3.7) adaptive training.  The PREGS microinjected 
goldfish produced a gain increase from 0.80 to 1.87 (a final VOR adaptive gain increase 
of 134%), whereas the CSF-control microinjected goldfish produced a gain increase from 
0.83 to 1.52 (final VOR adaptive gain increase of 83%). 
 Group data from six goldfish show the PREGS, when injected into the vestibulo-
cerebellum, significantly enhanced (NP Kolmogorov-Smirnov (KS) test; P<0.001) the 
acquisition of adapted VOR gain increases compared to CSF-control animals (n=7) 
during the 3 hour adaptive training period (Fig 3.8A).  PREGS injected animals produced 
significantly greater final VOR of 1.92 ± 0.13 resulting in a gain change of 101%.  In 
contrast, CSF-control animals produced final VOR gain change of 1.49 ± 0.13 resulting 
in a gain change of 88%. 
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 The effect of various concentrations of PREGS on the acquisition phase of VOR 
adaptive gain increases is presented in Table 3.7.  These data illustrate that injection of 
PREGS enhances adaptive VOR gain increases and that the effects of PREGS on the Vis-
VOR and the VOR adaptive gain increases are not in a dose dependent manner.  In 
addition, these data demonstrate that VOR gain increases were only enhanced at the 
specific concentration of 100µM. 
    6.  Effect of PREGS on Adaptive Vis-VOR and VOR Gain Decreases (Microinjection) 
 These microinjection experiments were similar to that conducted for gain 
increases, but involved adapted gain decreases of the VOR.  Prior to adaptive training 
toward 0X, PREGS (1, 10, 100, 1000 µM) did not appear to have an effect on Vis-VOR or 
VOR gains prior to adaptive training.  Significant effect of PREGS on adaptive Vis- 
VOR gain decreases at the 1000µM concentration (figure not shown) after the 3 hour 
adaptation period in comparison to CSF-control group was observed.  Curiously, no 
significance was found at the 100 µM concentration, which significantly enhanced Vis-
VOR and VOR adaptive gain increases (Fig 3.10B). 
 Group data from five gold fish that received 100 µM PREGS, when microinjected 
into the vestibulo-cerebellum, did not significantly enhance (NP Kolmogorov-Smirnov 
(KS) test; P<0.272; N.S.) the acquisition of adapted Vis-VOR gain decreases compared 
to CSF-control animals (n=6) during the 3 hour training period (Fig 3.10B).  After 3 
hours of adaptive training to decrease reflex gain, CSF-control animals produced a final 
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Figure 3.7. Individual Effect of PREGS on Adaptive VOR Gain Increases 
(Microinjection). 
Comparison of raw eye movements (top trace in each data sample), eye velocity (middle 
trace) and reconstructed eye movements (lower trace; fast eye movement phases 
removed) of the VOR following infusion of CSF as a control or pregnenolone sulfate 
(100µM) into an individual goldfish.  These recordings were taken before (0 hours) and 
after (3 hours) VOR adaptive training to increases gain.  The number included with each 
data set is the reflex gain value for the reconstructed eye movements as determined by 
FFT analysis.  The pregnenolone sulfate fish produced a final adaptive VOR gain 
increases of 134%.  In comparison, the CSF-control fish produced a final VOR gain 
increases of 83%. 
 
 
 
  
69 
 
 
 
A     VOR 
 
 
B     Vis-VOR 
 
 
Figure 3.8. Effect of PREGS on Adaptive VOR and Vis-VOR Gain Increases 
(Microinjection). 
Group data confirms that animals injected with pregnenolone sulfate (100 µM, red 
triangles) produced greater VOR adapted gain increases after 3 hours of training 
compared to CSF-control animals (large squares).  After 3 hours of adaptive training, 
animals receiving pregnenolone sulfate increased their VOR gain by 101%.  In 
comparison, CSF-control animals only increased their VOR gain by 88% 
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Table 3.7.  Adapted increase VOR gains for various concentrations of PREGS vs. CSF-control 
 
 
Condition n 
Normal 
Post-Infusion 
Gain @ 0 hr 
 
Adapted 
Gain @ 1 hr 
 
Adapted 
Gain @ 2 hr 
 
Adapted 
Gain @ 3 hr 
Kolmogorov-
Smirnov test 
P-value 
Control 7 0.79 ± 0.05 1.02 ± 0.07 1.30 ± 0.10 1.49 ± 0.13  
1µM 5 0.88 ± 0.08 1.03± 0.12 1.29 ± 0.19 1.48 ± 0.19 0.835 
10µM 5 0.79 ± 0.06 1.15 ± 0.09 1.56± 0.06 1.75 ± 0.05 0.975 
100µM 6 0.96 ± 0.05 1.31 ± 0.09 1.70 ± 0.13 1.92 ± 0.13 0.001 
1000µM 5 0.88 ± 0.03 1.11 ± 0.08 1.33± 0.12 1.51 ± 0.10 0.698 
 
 
 Values for adapted gain are means ± SEM.  Multiple KS was performed using the Bonferroni correction.  The target p-
value for significance testing, 0.05 was divided by the number of comparisons, in this case 4.  The new target p-value was 
0.0125.  The only concentration that produced significant enhancement of VOR gain increase adaptation compared to control 
animals was 100µM (NP Kolmogorov-Smirnov (KS) test). 
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Vis-VOR gain of 0.08 ± 0.02 resulting in a gain change of 65%.  Goldfish microinjected 
with PREGS produced a final Vis-VOR gain 0.11 ± 0.04, a gain change of 76%.  
 The effect of PREGS concentrations was also tested on the VOR.  Goldfish (n=6) 
receiving 100 µM of PREGS did not appear to experience a significant decrease below 
baseline for VOR training to a gain of 0X compared to CSF-controls (NP Kolmogorov-
Smirnov (KS) test; P<0.965; N.S.).  This is illustrated by comparing the individual VOR 
eye movements recorded from a goldfish that received PREGS with that of a goldfish that 
received CSF-control before (0 hours) and after (3 hours; Fig 3.9) adaptive training.  The 
PREGS goldfish produced a gain decrease from 0.90 to 0.25 (a final VOR adaptive gain 
decrease of 72%) and the CSF-control goldfish produced a decrease from 0.81 to 0.24 (a 
final VOR adaptive gain decrease of 70%). 
 Group data from 6 goldfish confirms results seen from individual animals.  Data 
shows that PREGS, when injected into the vestibulo-cerebellum, did not significantly 
enhance (NP Kolmogorov-Smirnov (KS) test; P<0.965; N.S.) the acquisition of adapted 
VOR gain decreases compared to CSF-control animals (n=6) during the 3 hour adaptive 
training period (Fig 3.10A).  CSF-control animals produced final VOR gain of 0.28 ± 
0.05 resulting in a gain change of 68%.  PREGS injected animals produced a final VOR 
gain of 0.29 ± 0.06 resulting in a gain change of 69%.  At no time during the adaptation 
period did animals’ microinjected with PREGS appear to produce a significant decrease 
in their overall VOR in comparison to the CSF-control animals. 
 The effect of various concentrations of PREGS on the acquisition phase of VOR 
adaptive gain decreases is presented in Table 3.8.  These data illustrate that no 
concentration of PREGS appears to significantly enhance adaptive VOR gain decreases. 
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    7.  Effect of PREGS on Adaptive VOR Gain Increase After First Being Trained to 
Decrease Adaptive VOR Gains (Microdialysis) 
 In these final experiments, goldfish were trained to decrease VOR gain and then 
infused via microdialysis with either PREGS (1 or 10µM) or CSF-control followed by 3 
hour training to increase VOR gain.  These experiments were performed to see if PREGS 
animals could significantly reverse their decrease VOR gain.  The concentrations used in 
these experiments (1 or 10µM) were chosen because they showed the most significant 
increase above baseline in the previous microdialysis increase experiments.  Although 
these concentrations significantly enhanced adaptive VOR gain increases when 
microdialyzed into the vestibulo-cerebellum, animals infused with these concentrations 
did not appear to significantly recover from learned decrease VOR gain. 
 Group data from five goldfish that received 10µM did not experience a significant 
increase above baseline in comparison to CSF- control animals (Fig. 3.11).  After the first 
adaptive training period, training to decrease reflex gain, there was no significant change 
in the gain of these animals in comparison to CSF-control animals.  After the second 
adaptive training period; training to increase reflex gain, CSF-control animals (n=6) 
produced a final VOR gain of 0.83 ± 0.11.  The PREGS animals produced a final VOR 
gain of 0.91 ± 0.09 (NP Kolmogorov-Smirnov (KS) test; P<0.090; N.S.; Fig 3.11). 
 The effect of both concentrations of PREGS during the two acquisition phases of 
VOR adaptation is presented in Table 3.9.  Interestingly, the two most effective 
concentrations in the microdialysis adaptive increase experiments did not appear to 
significantly enhance VOR gains after the animals were first trained to decrease their 
VOR gains. 
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C.  Discussion 
 The present investigation demonstrated that infusion of PREGS into the vestibulo-
cerebellum of goldfish via microdialysis or bilateral microinjection significantly 
enhanced adaptive VOR gain increases, but not adaptive VOR gain decreases without 
altering the normal operation of the reflex prior to adaptive training.  In the microdialysis 
increase experiments, we demonstrated that only the intermediate concentrations of 
PREGS, (1 & 10µM), enhanced adaptive VOR gain increases.  In the microinjection 
increase experiments, we show that only the 100µM significantly enhanced adaptive 
VOR gain increases.  The reason why lower concentrations were able to significantly 
enhance adaptive VOR gain increases when microdialyzed into the vestibulo-cerebellum 
compared to microinjection may be due to two important factors.  (1) In the microdialysis 
studies, the animals received approximately 10% of the total concentration being infused 
and (2) this infusion took place over a 4 hour period; constantly bathing the neurons of 
the cerebellum with the drug. 
 For adaptive VOR gain decreases, PREGS infusion had an effect that was 
markedly different than adaptive VOR gain increases in both studies.  Concentrations that 
produced significant enhancements in adaptive VOR gain increases did not appear to 
affect adaptive VOR gain decreases.  In addition, it was demonstrated that PREGS did 
not appear to significantly reverse decreases in VOR gains, suggesting the possibility that 
the pharmacological mechanisms involved in adaptive VOR gain increases and decrease 
are separate and distinct.  This work disagrees with Ito’s model for the VOR which states 
that increases and decreases in adaptive VOR gain share similar properties due to their 
shared mechanism (Ito et al. 1972, 1982).  However, several recent studies have also 
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Figure 3.9. Individual Effect of PREGS on Adaptive VOR Gain Decreases 
(Microinjection). 
Comparison of raw eye movements (top trace in each data sample), eye velocity (middle 
trace) and reconstructed eye movements (lower trace; fast eye movements removed) of 
the VOR following infusion of CSF as a control or pregnenolone sulfate (100µM) into an 
individual goldfish.  These recordings were taken before (0 hours) and after (3 hours) 
VOR adaptive training to increases gain.  The number included with each data set is the 
reflex gain value for the reconstructed eye movements as determined by FFT analysis.  
The pregnenolone sulfate fish produced a final adaptive VOR gain decreases of 72%.  In 
comparison, the CSF-control fish produced a final VOR gain decreases of 70%. 
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A     VOR 
 
 
B     Vis-VOR 
 
 
Figure 3.10. Effect of PREGS on Adaptive VOR and Vis-VOR Gain Decreases 
(Microinjection) 
Group data confirms that animals injected with pregnenolone sulfate (100µM, red 
triangles) do not produce greater VOR adapted gain decreases after 3 hour of training 
compared to CSF-control animals (large squares).  After 3 hours of adaptive training, 
animals receiving pregnenolone sulfate decreased their VOR gain by 69%.  In 
comparison, CSF-control animals decreased their VOR gain by 68%. 
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Table 3.8.  Adapted decrease VOR gains for various concentrations of PREGS vs. CSF-control 
 
 
Condition n 
Normal 
Post-Infusion 
Gain @ 0 hr 
 
Adapted 
Gain @ 1 hr 
 
Adapted 
Gain @ 2 hr 
 
Adapted 
Gain @ 3 hr 
Kolmogorov-
Smirnov test 
P-value 
Control 6 0.88 ± 0.07 0.65 ± 0.05 0.44 ± 0.05 0.28 ± 0.05  
1µM 4 0.89 ± 0.06 0.55 ± 0.07 0.38 ± 0.08 0.27 ± 0.05 0.1757 
10µM 5 0.83 ± 0.02 0.72 ± 0.03 0.54 ± 0.07 0.36 ± 0.07 0.277 
100µM 6 0.94 ± 0.03 0.69 ± 0.03 0.44 ± 0.07 0.29 ± 0.06 0.7353 
1000µM 5 0.96 ± 0.08 0.62 ± 0.04 0.42 ± 0.05 0.32 ± 0.06 0.6714 
 
 
 Values for adapted gain are means ± SEM.  Multiple KS was performed using the Bonferroni correction.  The target p-
value for significance testing, 0.05 was divided by the number of comparisons, in this case 4.  The new target p-value was 
0.0125.  There appears to be no enhancement of VOR gain decrease adaptation compared to control animals for any 
concentration of PREGS. 
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     VOR 
 
 
 
Fig 3.11. Effect of PREGS on Adaptive VOR Gain Increase After First Being 
Trained to Decrease Adaptive VOR Gains (Microdialysis) 
Group data confirms that animals microdialyzed with pregnenolone sulfate (10µM, red 
triangles) do not produce greater VOR adapted gain increases after first being trained to 
decrease their VOR gain compared to CSF-control animals (large squares).  After the 
second adaptive training, animals receiving pregnenolone sulfate increased their VOR 
gain by 90%.  CSF-control animals increased their VOR gain by 118%. 
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Table 3.9.  Reversal of adapted decrease VOR gains for various concentrations of PREGS vs. CSF-control 
 
 
Condition n 
Normal 
Post-
Insertion 
Gain @ 0 
hr 
Adapted 
Decrease 
Gain @ 1 
hr 
Adapted 
Decrease 
Gain @ 2 
hr 
Adapted 
Decrease 
Gain @ 3 
hr 
Post-
Dialysis 
Adapted 
Increase 
Gain @ 1 
hr 
Adapted 
Increase 
Gain @ 2 hr 
Adapted 
Increase 
Gain @ 3 
hr 
Kolmogorov-
Smirnov test 
P-value 
Control 6 0.86 ± 0.02 0.53 ± 0.03 0.34 ± 0.03 0.26 ± 0.04 0.49 ± 0.06 0.62 ± 0.06 0.83 ± 0.11  
1µM 5 0.85 ± 0.03 0.47 ± 0.03 0.28 ± 0.03 0.20 ± 0.03 0.53 ± 0.04 0.75 ± 0.08 0.95 ± 0.12 0.325 
10µM 5 0.85 ± 0.03 0.60 ± 0.07 0.43 ± 0.09 0.27 ± 0.08 0.54 ± 0.08 0.70 ± 0.04 0.91 ± 0.09 0.090 
 
 
 Values for adapted gain are means ± SEM.  Multiple KS was performed using the Bonferroni correction.  The target p-
value for significance testing, 0.05 was divided by the number of comparisons, in this case 2.  The new target p-value was 
0.025.  There appeared to be no enhancement of VOR gain increase adaptation compared to control animals for both 1 and 
10µM of PREGS after they were first trained to decrease VOR gains. 
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demonstrated the possibility that adaptive VOR gain changes may operate by separate 
plasticity mechanisms.  An early study illustrated that adaptive VOR gain increases 
passively decayed more rapidly than adaptive VOR gain decreases (Miles & Eighmy 
1980).  Furthermore, it has been shown that adaptive VOR gain increases can be more 
actively reversed than adaptive VOR gain decreases (Boyden & Raymond 2003).  Lastly, 
it has been reported that decreasing VOR gain by training with only one eye viewing the 
stimuli causes a decrease VOR gain in the other eye, but increasing the gain in one 
exposed eye does not result in an increased gain in the other  (McElligott & Wilson, 
2001).  The summation of the above studies would suggest that the distinct properties of 
adaptive VOR gain increases and decreases are mediated by different pharmacological 
mechanisms and possibly at different neuronal sites. 
 The present work also agrees with previous work in our laboratory demonstrating 
that the infusion of the neurosteroid estradiol into the vestibulo-cerebellum enhanced 
adaptive VOR gain increases, but not gain decreases.  In contrast, it has been 
demonstrated from our laboratory that the infusion of other neurosteroids such as, 
testosterone, progesterone and 17α-20β progesterone, did not enhance nor inhibit 
adaptive VOR gain increases or decreases.  The summation of these studies would 
suggest that the structure of a steroid plays an important part in its effect on VOR 
adaptation.  Both testosterone and progesterone contain a double bonded oxygen 
molecule and different carbon double bonds. 
 PREGS acts as an antagonist to the GABAA receptor and AMPA/KA receptors 
and as an agonist of the NMDA receptor.  Previous work in our laboratory has shown that 
microdialysis of muscimol into the vestibulo-cerebellum inhibited adaptive VOR gain 
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increases and decreases in a dose dependent manner (McElligott, 2002).  In addition, it 
was recently reported that bilateral infusion of the quinoxaline-dione compound, 6-
cyano-7-nitroquinoxaline-2,3 dione (CNQX), a potent and competitive antagonist to the 
AMPA/KA receptors inhibited both adaptive VOR gain increases and decreases (Carter 
& McElligott, 2005).  Moreover, a study in which D-AP5 (the NMDA antagonist) was 
microinjected into the vestibulo-cerebellum illustrated inhibition of adaptive VOR gain 
increases, but not adaptive VOR gain decreases.  Since the effect of PREGS on the VOR 
was opposite to the results found using D-AP5, but affecting the same adaptive 
conditions (VOR adaptive gain increase) one might surmise that PREGS’ agonist action 
on the NMDA receptor is associated with enhancement of VOR gain increase. 
 Currently, the cerebellum is believed to be one of the neuronal sites where 
adaptation of the vestibulo-ocular reflex occurs.  Lesion and recording studies have 
reported the necessity of the cerebellum for the VOR.  Surgical lesions, pharmacological 
inactivation, and genetic disruption of the cerebellum have inhibited the ability to modify 
VOR gain changes (Ito et al.; 1982a, Koekkoek et al. 1997.; Lisberger et al.; 1984; 
Luebke & Robinson, 1994; McElligott et al.; 1998; Michnovicz & Bennet, 1987; Nagao, 
1983; Rambold et al.; 2002; Robinson, 1976; van Alphen et al.; 2002).  Vestibulo-ocular 
reflex adaptation results from a sustained mismatch between head rotation and the visual 
world producing the appropriate eye movement.  The mossy fibers activate the Purkinje 
cells and inhibitory interneurons through synaptic connections between granule cells and 
the parallel fibers.  NMDA receptors are localized in the glomeruli/granule cell complex 
and inhibitory interneurons (basket and stellate cells) of the cerebellum.  The granule cell 
layer is one of the predominant layers in the adult cerebellum.  Excitation of the NMDA 
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receptors on these neurons enhances the transmission of information regarding head 
position and velocity to the Purkinje cells, thereby enhancing adaptation of the VOR.  
Therefore, a possible site of action for PREGS might also be the glomeruli/granule cell-
NMDA receptors. 
 Originating from the inferior olivary nucleus, climbing fibers make synapses with 
Purkinje cell dendrites.  These synaptic connections relay visual-target information from 
the accessory optic system.  NMDA receptors do mediate transmission on the proximal 
dendrite of Purkinje cells corresponding with climbing fiber-Purkinje cell synapses in 
adult guinea pig (Kimura et al.; 1985a, 1985b; Sekiguchi et al.; 1987; Billard & Pumain, 
1989).  Excitation of these NMDA receptors by PREGS enhances the transmission of 
visual target information to the Purkinje cells and therefore enhances adaptation of the 
reflex.  Simultaneous pre and postsynaptic firing at the parallel fiber-Purkinje cell 
synapse may lead to a potentiation, similar to that observed in long-term potentiation 
(Petralia et al.; 1994; Casado et al.; 2000).  However, functional NMDA receptors have 
been reported to disappear from Purkinje cells after 2 weeks of age in rats (Crepel et al.; 
1983; Audinat et al.; 1990; Farrant & Cull-Candy, 1991; Krupa & Crepel, 1990; 
Lachamp et al.; 2005, Llano et al.; 1991; Dupont et al.; 1987; Metzger et al.; 2005).  The 
presence of cerebellar NMDA receptors in the Purkinje cells in goldfish has yet to be 
determined.  Cerebellar Purkinje cells project monosynaptic inhibitory (GABA) 
influences on vestibular neurons in the brainstem. 
 A recent study illustrated that PREGS acts by facilitating the actions of glutamate 
at presynaptic NMDA receptors (Gibbs et al.; 1999).  Another study demonstrated that 
the effects of PREGS could still be seen in the presence of tetrodotoxin, in which 
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neurotransmitter release occurs in an action potential-independent manner. (Mameli et 
al.; 2005)  Mameli and colleagues surmised that PREGS was significantly increasing the 
efficacy and/or potency of low glutamate level generated by quantal release and that 
PREGS was most likely enhancing Ca2+ influx through presynaptic NMDA receptors 
leading to an increase in glutamate release.  Therefore, it is plausible that the effects 
observed in this model system could be due to PREGS’ interaction with presynaptic 
NMDA receptors located at the parallel fiber-Purkinje synapse (Gibbs et al.; 1999).  
These findings indicate that the pharmacological mechanism of adaptive vestibulo-ocular 
reflex gain increases has similar characteristics to that of LTP. 
 The site of action of PREGS on the NMDA receptor complex is presently 
unknown.  The NMDA receptor/channel complex has several pharmacologically distinct 
modulatory sites that could be potential sites of action for PREGS.  Several studies have 
demonstrated that PREGS does not act competitively through the NMDA site or non-
competitively through the glycine (strychnine-insensitive) modulatory site, the polyamine 
modulatory site or any sites associated with the channel (Su et al.; 1988; Wu et al.; 1991; 
Irwin et al.; 1992; Fahey et al.; 1995).  In addition, several closely related steroids have 
demonstrated the ability to modulate NMDA-mediated [Ca2+]i responses in hippocampal 
neurons with a high degree of structural specificity (Irwin et al.; 1994).  These findings 
suggest the existence of one or more distinct allosteric modulatory site(s) for steroids on 
the NMDA receptor complex. 
 Alternative explanations should be considered since PREGS interacts with other 
neurotransmitter systems.  Monnet et al.; (1995) showed the PREGS blocked NMDA-
evoked release of [3H] norepinephrine in rat hippocampal slices, presumably through its 
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interaction with haloperidol-sensitive α receptors coupled to G-proteins.  In that study, 
micromolar concentrations of PREGS seemed to exert two opposite effects, direct 
potentiation and indirect inhibition, on NMDA-mediated responses in hippocampal 
neurons.  It is unclear how an indirect inhibition of NMDA-mediated events by PREGS 
leads to enhancing effects observed in these studies.  Another alternative possibility 
includes stimulation of the granule cell-parallel fiber synapse, resulting from changes in 
head position and acceleration causing an increase in Purkinje cell activity.  An increase 
in Purkinje cell activity produces a greater release of GABA onto relay neurons in the 
vestibular nuclei which in turns leads to modulation of the signal output to the 
oculomotor neurons leading to a change in eye position.  Since PREGS inhibits the 
GABAA receptor complex it is possible that microdialysis or bilateral infusion of PREGS 
into the vestibulo-cerebellum of goldfish could produce a disinhibition of Purkinje cell 
activity.  This disinhibition would produce a decrease in the release of GABA onto relay 
neurons in the vestibular nuclei leading to enhancement of the reflex.  Furthermore, since 
PREGS inversely modulates the GABAA and NMDA receptors, the effects present in 
these studies could be synergistic.  Finally, PREGS could enter the neurosteroid synthesis 
pathway after being converted to pregnenolone and act via one or more derivatives 
(Iwamori et al.; 1976; Romeo et al.; 1994). 
 The experiments presented in this thesis indicate that functional cerebellar NMDA 
receptors and/or GABAA receptors, located on granule and/or Purkinje cells, are 
important for adaptation of the VOR.  These studies suggest that NMDA receptors and/or 
GABAA receptors are necessary for VOR adaptive gain increases, but not gain decreases.  
Moreover, the data presented here suggest that the cerebellum may not be the site of 
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adaptive VOR gain decreases.  However, further experiments are needed to elucidate the 
mechanism of action of PREGS in this model system.  Future studies should also address 
the unanswered questions: (1) What is the pharmacological mechanism of VOR adaptive 
gain decreases?  (2) Where is the anatomical site(s) of VOR gain increase and decrease; 
the cerebellum, vestibular nuclei or both, and are the sites(s) the same for both types of 
adaptation?  (3) Does VOR adaptive gain decreases require Ca2+ from cerebellar NMDA 
receptors or from some other source? 
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CHAPTER 4: THE EFFECTS OF PREGNENOLONE SUFLATE ON THE 
RETENTION PHASE OF VESTIBULO-OCULAR ADAPTATION 
 
 
A.  Introduction 
 The proposal of neurosteroid-induced memory improvements in aged mice 
(Roberts, 1990) has led to a focus on the physiological role of neurosteroids in age-
related decline of cognitive and memory abilities.  Studies in humans and animals have 
demonstrated that the levels of cortisol or corticosterone in the plasma increase with age 
and are related to memory abilities in older subjects (Issa et al.; 1990; Lupien et al.; 1998; 
Vallée et al.; 1999).  Moreover, it has been reported that concentration of 
dehydroepiandrosterone (DHEA) and its sulfated ester (DHEAS) in the blood markedly 
decreased with age in humans (Orentreich et al.; 1984, 1992; Vermeulen, 1995).  DHEA 
and DHEAS belong to a class of neurosteroids that is synthesized and accumulates in the 
nervous system to levels at least in part independent of peripheral steroidogenesis.  This 
group of neurosteroids also includes pregnenolone, pregnenolone sulfate and 
progesterone. 
 Behavioral studies have shown that PREGS has memory-enhancing properties in 
several paradigms, when administered after the acquisition trial.  PREGS facilitated the 
retention of passive avoidance when injected subcutaneously (s.c.) in rats after 
acquisition (Isaacson et al., 1995).  PREGS improved the retention of active avoidance at 
very low doses when administered within the ventricles (i.c.v.) or locally into the 
amygdala, hippocampus, septum or mammillary bodies of mice (Flood et al., 1992 & 
1995).  In all these limbic structures, the effects of PREGS administration exhibited an 
inverted U-shaped dose-response curve, typical of memory-enhancing compounds.  
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PREGS has also demonstrated promnesic effects in the water maze in female 
ovariectomized rates after subcutaneous administration and in appetitive learning tasks in 
male mice after i.c.v. administration (Frye et al.; 1995 & Meziane et al;, 1996).  
Additionally, it has been demonstrated that deficits induced by the following drugs: the 
competitive NMDA receptor antagonist D-AP5 and CPP (3-((±)-2-carboxypiperazin-4-
yl)-propyl-1-phosphonic acid) in a Y-maze active avoidance and passive avoidance 
memory tasks respectively, the non-competitive NMDA receptor antagonist dizocilpine 
maleate (MK-801) in passive avoidance and ethanol or scopolamine in appetitive 
learning tasks were ovecomed by the administration of PREGS (Mathis et al.; 1996, 
1994; Cheney et al.; 1995; Melchoir & Ritzmann 1996). 
 Although there is abundant data illustrating the memory-enhancing effects 
following the administration of pregnenolone, pregnenolone sulfate, DHEA and DHEAS, 
the physiological relevance of these effects is very much open for discussion.  First, the 
majority of these studies involve an animal, usually a rat or mouse, having to avoid 
electrical footshocks (active or passive avoidance) or search for a food reward after food 
deprivation.  Second, the range of doses used in these pharmacological studies varies 
greatly from one study to another.  Lastly, in all the previous behavioral studies PREGS 
was administrated systemically, allowing the drug far transport abilities throughout the 
body instead a more controlled and centralized infusion.  This casts doubt on the 
physiological significance of these pharmacological studies. 
 In the studies described here we investigated the effects of PREGS on the 
retention (memory) phase of VOR adaptation.  In our experimental design there is no 
punishment or reward that may influence the motivational or emotional status of the 
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animals.  Moreover, the administration of PREGS is more controlled, in that it is only 
reaching one area, the vestibulo-cerebellum.  In these retention studies the animals were 
trained to either increase or decrease their adaptive VOR gain and then allowed to re-
adapt for an additional 3 hours.  PREGS or CSF-control was infused either before 
adaptive training or after, to test the effect of PREGS on retention.  Retention was 
evaluated as the ability of the animals to retain their previously adapted VOR gain 
increases and decreases over time. 
 Previous work from our laboratory showed that infusion of muscimol into the 
vestibulo-cerebellum of goldfish inhibited retention increases and decreases.  In addition, 
microinjection of D-AP5 into the vestibulo-cerebellum of goldfish inhibited retention 
gain increases.  The results from those studies suggested that both GABAA and NMDA 
receptors are necessary for the normal retention of adaptive VOR gain increases.  In 
addition, those studies suggested that GABAA receptors and not NMDA receptors are 
necessary for the normal retention of adaptive VOR gain decreases.  The results 
presented here demonstrate that pregnenolone sulfate, a GABAA antagonist and NMDA 
agonist did not enhance or inhibit the retention phase of VOR adaptation.  There was no 
difference in the results when PREGS was administered before or after the acquisition 
training period.  These results would suggest that there are behavioral and 
pharmacological differences between the acquisition (learning) and retention (memory) 
phases of vestibulo-ocular reflex adaptation. 
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B  Results 
    1.  Effect of PREGS on the Retention Phase of Adapted Gain Increases When Infused 
Before Adaptation 
 In this set of experiments, the effect of PREGS on the retention phase of VOR 
adaptation was examined.  A number of goldfish received either PREGS or CSF-control 
microinjection prior to the acquisition phases of VOR adaptive gain increases.  These 
animals were then allowed to re-adapt for an additional three hours (retention phase).  
During the retention phases the animals were allowed to rest in the light with no 
vestibular stimuli.  It has been shown that allowing the animals to rest in dark causes a 
natural suppression of the reflex (McElligott 1995).   As was seen with earlier 
microinjection increases, PREGS significantly enhanced adaptive VOR gain increases at 
the end of the 3 hour acquisition phase.  At the end of the 3 hour retention period it was 
seen that CSF-control animals (n=7) had a final VOR gain of 1.04 ± 0.11.  These goldfish 
retained approximately 79% of their adapted gain during the retention phase.  The 
animals treated with PREGS (100 µM; n=6) produced statistically significant final VOR 
gain of 1.36 ± 0.05 (NP Kolmogorov-Smirnov test; P<0.0001; Fig 4.1A). 
 Although, the graph shows that these animals had a significantly higher VOR gain 
versus CSF-control animals at the end of the 3 hour retention period, the animals treated 
with PREGS retained approximately 76% of their adaptive gain.  Similar percentages 
were seen for the other concentrations of PREGS and CSF-control. The significance seen 
at the end of the retention phase was due to the fact that the PREGS animals learned 
better than the CSF-control animals during the prior adaptive training phase.  The results 
of these retention studies illustrate that PREGS when microinjected into the cerebellum  
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Fig 4.1. Effect of PREGS on the Retention Phase of Adapted Gain Increases & 
Decreases When Infused Before Adaptation. 
A) The effect of PREGS on the retention phase of the VOR when infused prior to 
adaptive training toward 3X.  B) The effect of PREGS on the retention phase of the VOR 
when infused prior to adaptive training toward 0X. 
 
 
 
  
90 
of goldfish did not appear to inhibit or enhance the retention of adapted gain increases 
more significantly than CSF-control animals. 
    2.  Effect of PREGS on the Retention Phase of Adapted Gain Decreases When Infused 
Before Adaptation 
 In this set of experiments, the effect was examined on animals that received either 
PREGS or CSF-control microinjection prior to the acquisition phase of VOR adaptive 
decreases.  Similar to the retention increase experiments the animals were allowed to re-
adapt for an additional 3 hours in the light with no vestibular stimuli.  As previously 
noted, the injection of PREGS into the vestibulo-cerebellum did not appear to affect pre-
adaptive performance before the acquisition period.  Data obtained during the post-
adaptation period (retention phase) showed that CSF-control animals (n=6) produced a 
final VOR gain of 0.47 ± 0.07.  The animals treated with PREGS (100µM; n=6) did not 
appear to produce statistically significant VOR gain at the end of the post-adaptation 
phase, 0.46 ± 0.05 (NP Kolmogorov-Smirnov test; P<0.333; Fig 4.1B).  The results of 
these experiments demonstrate that PREGS when microinjected into the vestibulo-
cerebellum of goldfish did not appear to inhibit or enhance the retention of adapted gain 
decreases more significantly than CSF-control animals. 
    3.  Effect of PREGS on the Retention Phase of Adapted Gain Increases When Infused 
After Adaptation 
 In this series of experiments, the effect of PREGS on the retention phase of VOR 
adaptive gain increase was tested by injecting PREGS after the 3 hour training period.  In 
these experiments, a bilateral microinjection probe was inserted into the vestibulo-
cerebellum prior to the acquisition phase.  Infusion of CSF-control or PREGS was carried 
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out after the completion of the 3 hour adaptive training toward 3X.  During the retention 
period, the animals rested in the light without vestibular stimulation except during the 
VOR testing periods.  Group data obtained during the adaptation period showed that 
CSF-control animals (n = 5) and experimental group (PREGS 100µM; n=5) increase their 
gain in a similar manner (final VOR gains 1.60 ± 0.16 vs. 1.64 ± 0.10, respectively).  
Data obtained during the post-adaptation period (retention) showed that CSF-control 
animals retained approximately 73% of their adapted gain, producing a final VOR gain of 
1.17 ± 0.05.  The PREGS treated animals which produced a final VOR gain of 1.23 ± 
0.08 at the end 3 hour training period, retaining approximately 75% of their adapted gain 
(Fig 4.2A).  Similar percentages were obtained for the other concentrations of PREGS. 
The results of these experiments demonstrate that PREGS when microinjected into the 
vestibulo-cerebellum of goldfish after adaptive training, did not appear to inhibit or 
enhance the retention of adapted gain decreases more significantly than CSF-control 
animals. 
    4.  Effect of PREGS on the Retention Phase of Adapted Gain Decreases When Infused 
After Adaptation  
 In this final series of experiments, the effect of PREGS on the retention phase of 
an adapted VOR gain decrease was examined.  Similar to the above retention 
experiments for gain increases, animals received either PREGS (100µM; n=5) or CSF-
control injection (n=6) after the decrease acquisition phase and were then allowed to 
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Figure 4.2. Effect of PREGS on the Retention Phase of an Adapted Gain Increase 
& Decrease When Infused After Adaptation. 
A) The effect of PREGS on the retention phase of the VOR when infused after adaptive 
training toward 3X.  B) The effect of PREGS on the retention phase of the VOR when 
infused after to adaptive training toward 0X. 
 
 
 
  
93 
re-adapt for an additional 3 hours.  During the retention phase, the animals remained 
stationary in the light with no vestibular stimuli except for VOR testing periods.  The data 
acquired showed that during the acquisition training period, the CSF-control group and 
the animals that received 100µM of PREGS decreased their gain in a similar manner with 
final VOR decrease gains of 0.34 ± 0.09 and 0.32 ± 0.05, respectively.  During the 
retention phase, the CSF-control group produced a final VOR decrease gain of 0.50 ± 
0.08 while the PREGS animals produced a final VOR decrease gain of 0.50 ± 0.05 (NP 
Kolmogorov-Smirnov test; N.S.; Fig 4.2B).  These data show that PREGS did not appear 
to enhance or inhibit the retention phase of VOR decrease adaptation. 
C.  Discussion 
 The results presented in this study show that bilateral injection of PREGS, a 
GABAA antagonist and NMDA agonist, into the vestibulo-cerebellum of goldfish did not 
enhance nor inhibit retention of adaptive VOR gain changes when infused before the start 
of adaptive training.  Moreover, the bilateral injection of PREGS did not appear to 
enhance or inhibit the retention phase of VOR adaptation when infused after adaptive 
training.  These results are in sharp contrast to the memory-enhancing effects of PREGS 
reported in other behavioral studies (Isaacson et al.; 1995; Flood et al.; 1992 &1995; Frye 
et al.; 1995; Meziane et al.; 1996; Mathis et al.; 1994 & 1996; Cheney et al.; 1996; 
Melchoir & Ritzmann, 1996).  In addition, these results presented in this thesis contradict 
the data from behavioral studies reported from our laboratory.  We demonstrated that 
bilateral injection of muscimol inhibited both retention increases and decreases.  
Moreover, we showed that bilateral injection of D-AP5 inhibits retention increases only.  
These studies suggest the both GABAA and NMDA receptors are involved in the 
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retention phase of VOR adaptation.  A possible explanation for the marked differences 
illustrated in this thesis, would suggest that acquisition and retention occur by different 
pharmacological mechanisms and/or their site of adaptation requires different anatomical 
structures. 
 Multiple plasticity mechanisms may be used to maintain motor memories over 
various time scales.  Consolidation is a transformation in the way a memory is 
programmed.  Marr (1971) hypothesized that consolidation of memory may involve the 
redistribution of information between different parts of the brain.  Application of this 
hypothesis to motor learning in the VOR has led to the idea that the motor memory for a 
learned change in VOR gain is transferred from the cerebellar cortex to the vestibular 
nuclei (Galiana, 1986; Nagao & Kitazawa, 2003; Peterson et al.; 1991).  Thus the role of 
the cerebellum may change with time after acquisition of learning. 
 Another possible mechanism is that PREGS is inversely modulating the NMDA 
receptors while blocking the GABAA receptors.  Information regarding head position and 
acceleration is carried by the cerebellar mossy fibers originating from the semi-circular 
canals, which activate Purkinje cells and inhibitory interneurons through synaptic 
connections with granule cells-parallel fibers, to the cerebellum.  NMDA receptors have 
been localized in the glomeruli/granule cell complex.  Inhibition of NMDA receptors in 
the glomeruli/granule cell complex would prevent the transmission of information 
regarding head position and acceleration to the Purkinje cells, while inhibition of the 
GABAA receptors in the glomeruli/granule cell complex would prevent the transmission 
of information regarding head position and acceleration to the Purkinje cells.  
Futhermore, inhibition of the GABAA receptors in the glomeruli/granule cell complex 
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would lead to an enhancement of the transmission of information regarding head position 
and acceleration to the Purkinje cell; resulting in a cancellation of effects and producing 
neither inhibition nor enhancement of the reflex. 
 Another possible mechanism of action is that PREGS is inversely modulating 
NMDA receptors at the parallel fiber-Purkinje cell synapse.  Synaptic connections 
between the climbing fibers and Purkinje cell dendrites relay information regarding 
visual target to the cerebellum.  Inverse modulation of presynaptic NMDA receptors 
located at the parallel fiber-Purkinje synapse could prevent the transmission of visual 
target information to the Purkinje cells, while blocking the GABAA receptors in Purkinje 
cells could lead to an enhancement of the transmission, causing these responses to cancel 
each other out and resulting in no effect of PREGS on the retention phase of VOR 
adaptation.  Lastly, there could be a combination of the above effects, in which inverse 
modulation of the NMDA receptors in the glomeruli/granule cell complex would lead to 
an enhancement of the transmission of information regarding head position and 
acceleration to the Purkinje cell.  At the same time, enhancement of the transmission of 
visual target information by inhibition of the GABAA receptors in the Purkinje cells and 
vice versa could also be plausible mechanisms by which PREGS is acting on the 
retention phase of VOR adaptation. 
 Further studies are necessary to examine the role of NMDA and GABAA 
receptors on VOR neuroplastic change with a particular emphasis on the retention phase 
of VOR adaptation.  The goal of these studies would be to determine if VOR gain 
increase and decrease retention are controlled by GABAA and NMDA receptors as 
concluded from earlier research in our laboratory.  In addition, further research is needed 
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to determine the following e questions: (1)  What are the pharmacological events between 
the acquisition phase (learning) and retention (memory) phase of VOR adaptation? (2)  
Where is the anatomical site(s) for acquisition phase (learning) and retention (memory) 
phase of VOR adaptation? 
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CHAPTER 5: EVOLUTIONARY CONSERVATION OF CYTOCHROME-P450 
SIDE CHAIN CLEAVAGE ENZYME 
 
 
A.  Introduction 
 Pregnenolone is produced in the peripheral steroidogenic glands and formed from 
cholesterol by the oxidative side-chain cleavage reaction, which is catalyzed by a specific 
enzyme, cytochrome P450 side chain cleavage enzyme.  Therefore, cytochrome P450scc 
is essential for the formation of pregnenolone in the brain.  In addition to peripheral 
steroidogenic glands, it has been established that de novo steroidogenesis from 
cholesterol occurs in mammalian brain as well as non-mammalian brains. 
 Certain structures in the mammalian brain have been shown to possess the 
cytochrome P450scc enzyme.  Recent studies have demonstrated that both P450scc 
protein and its messenger RNA are expressed in myelinated regions of white matter 
throughout the rat brain (Baulieu, 1991; Baulieu and Robel 1990; Jung-Testas et al., 
1989; Compagnone et al., 1995; Le Goascogne et al., 1987; Mellon et al., 1993; Ukena et 
al., 1998).  Employing immunohistochemical techniques, cytochrome P450scc-like 
protein was identified in the cerebellar cortex.  The immunoreaction was restricted to 
large cell bodies lying at a narrow zone between the molecular and granular layers and to 
fibers spreading into the molecular layer.  The distribution of immunoreactive cell bodies 
and fibers in the cerebellar cortex coincided with the location of stomata and dendrites of 
Purkinje cells (Ukena et al., 1998, 1999).  Immunolabeling and Western Blot analysis 
confirmed that P450scc-like immunoreactive cells are not glial cells, but cerebellar 
Purkinje cells.  This result further suggests that P450scc-like protein is concentrated in 
some intracellular organelle, such as cytoplasmic mitochondria.  Furthermore, in this 
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mammalian species, P450scc appears in the Purkinje cell immediately after its 
differentiation and the expression of the enzyme persists during neonatal development 
into adulthood. 
 Biochemical and immunohistochemical studies indicate that avian brain possesses 
cytochrome P450scc and produces pregnenolone from cholesterol.  Localization of the 
P450scc in the brain was found in the cerebellar cortex (Tsutsui et al., 1997; Usui et al., 
1995).  The distribution of immunoreactive cell bodies and fibers in the cerebellar cortex, 
confirmed the presence of P450scc in Purkinje cells (Tsutsui et al., 1997; Usui et al., 
1995).  Moreover, pregnenolone and pregnenolone sulfate concentrations were measured 
using a specific radioimmunoassay (RIA).  The concentration of pregnenolone in adult 
birds was higher in the brain than in the plasma.  Although hypophysectomy greatly 
reduced pregnenolone concentration in the plasma, high levels of pregnenolone remained 
in the brain, suggesting that the accumulation of pregnenolone in the brain of birds was 
largely independent of peripheral steroidogenic glands.  Pregnenolone sulfate was also 
detected and localized in the brain.  These studies indicate that the avian brain possesses 
the cytochrome P450scc enzyme and produces pregnenolone from cholesterol. 
 In order to truly understand the biosynthesis of pregnenolone in the brain, one 
needs to also look at the process in lower vertebrates.  Recent studies have identified the 
presence of cytochrome P450scc-like protein in the cerebellar Purkinje cell of both 
Xenopus laevis and Rana nigromaculata (Takase et al., 1999).  Moreover, it was 
demonstrated that the amphibian brain produced pregnenolone and pregnenolone sulfate.  
An immunoreactive protein band of electrophoretic mobility in the proximity of bovine 
cytochrome P450scc was detected in the Xenopus laevis brain by Western Blot analysis.  
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In addition, the concentrations of pregnenolone and pregnenolone sulfate were greater in 
the brain than in the gonads and plasma of Xenopus laevis.  Therefore, it can be 
concluded from these findings that cytochrome P450scc is a highly conserved property of 
vertebrate brains since both higher and lower vertebrate species possess P450scc. 
 In this work, immunohistochemical techniques were employed to investigate the 
conservation of the enzymatic mechanism of pregnenolone formation.  Specifically, we 
attempted to detect and localize cytochrome P450scc in the brain of goldfish, which to 
the best of our knowledge has not been previously demonstrated. 
B.  Results 
 Previous studies have demonstrated the presence of P450scc-like protein in both 
higher and lower vertebrates, suggesting that cytochrome P450scc is evolutionarily well 
conserved.  The work presented in this thesis, examined the localization of P450scc-like 
immunoreactive cells in the female goldfish, Carassius auratus brain.  As shown in Fig 
5.1, an immunoreaction with the anti-P450 serum was observed in the brain of the 
goldfish, specifically in the cerebellum.  The immunoreactive cells were restricted to cell 
bodies lying at the Purkinje cell layer, which lies between the molecular and granular 
layers of the cerebellum. 
C.  Discussion 
 The present investigation demonstrated a cytochrome P450scc-like protein in the 
brain of goldfish, Carassius auratus.  The results in this thesis illustrate that a 
cytochrome P450scc-like protein was localized in the cerebellum of goldfish, specifically 
in the Purkinje cell layer.  As the presence of cytochrome P450scc in the brain has been 
established in several mammalians species (Baulieu, 1991; Baulieu& Robel, 1990, 
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Figure 5.1. Localization of P450scc-like immunoreactive cells in the brain 
Immunohisotchemical staining with the antiserum to cytochrome P450scc in the Purkinje 
cell layer (P) between the molecular (M) and granular (G) layers in the cerebellum of 
female Carassius auratus. 
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Jung-Testas et al., 1989; Campagnone et al., 1995; Le Goascogne et al., 1987; Mellon et 
al., 1993; Ukena et al., 1999), in an avian species (Tsutsu et al, 1995,1997; Usui et al., 
1995) and amphibians (Takase et al., 1999), one can draw a more firm conclusion that the 
presence of cytochrome P450scc and the enzymatic mechanism involved in the formation 
of pregnenolone may be an evolutionary well conserved property of the vertebrate brain. 
 In addition, these findings suggests the formation of pregnenolone and 
pregnenolone sulfate in the cerebellum of goldfish, since cytochrome P450scc was 
localized in neurons in the brain, specifically in the Purkinje cells in the cerebellum.  
However, there are several questions with regard to goldfish that still needs to be 
addressed.  1)  Do goldfish possess pregnenolone and pregnenolone sulfate?  2) If so, in 
what regions (i.e., brain, gonad, plasma) are these hormones localized?  3)  What is the 
distribution of pregnenolone and pregnenolone sulfate in the brain?  4) Goldfish are 
seasonally breeding vertebrates, do the concentrations of pregnenolone and pregnenolone 
sulfate change during the breeding, post-breeding and hibernation seasons?  5)  Are the 
results found comparable for both sexes?  
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CHAPTER 6: SEASONAL CHANGES IN THE GONADOSOMATIC INDEX OF 
GOLDFISH 
 
 
A.  Introduction 
 Gonadosomatic index (GSI) has been widely used to monitor seasonal and 
experimental fluctuations in the gondal state of a large variety of teleost species.  The 
index, first employed by Meien (1927) makes the assumption that there is a constant 
arithmetic relationship between gonadal weight and body weight.  The value of index has 
been questioned for  (1) differential relative ovarian weights in goldfish, Carassius 
auratus, of differing body weights at certain times of the year has been reported 
(Delahunty & de Vlaming, 1980) and (2) species, fractional spawners that deposit eggs 
over several spawning over a period of several months.  This would allow the GSI to be 
identical at times as the gonad undergoes repeated oocyte maturation and release 
(Delahunty & de Vlaming, 1980; Yamazaki, 1962). 
 Most studies of the reproductive physiology of goldfish have employed small 
(<10cm long) laboratory-reared animals.  This study was undertaken to determine the 
seasonal gonadal changes in large laboratory-reared populations of a cyprinid fish, 
Carassius auratus and compare observations with published data of wild populations.  I 
would just like to make a note that it is often that laboratory results can be extrapolated to 
wild fish, one must take into account the complex interactions of environmental stimuli 
acting to regulate physiological events, such as gonadal maturation and gamete release.  
Therefore, one must be cautious when making such extrapolations. 
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B.  Results 
    1.  Changes in Gonadosomatic Index (GSI) of Females 
 The GSI levels in females increased steadily from April (4.10 ± 0.01; Fig 5.1) to 
May (5.17 ± 0.01; Fig 5.1) reaching maximal GSIs in June (6.36 ± 0.02; Fig 5.1).  
Spawning activity was first evident in late May to early June.  For the duration of the 
summer, the GSI of the females steadily decreased from July (3.78 ± 0.01; Fig 6.1) to 
September (2.72 ± 0.01; Fig 6.1).  In the beginning of October, the GSI increased to 3.38 
± 0.02 (Fig 6.1).  These levels were comparable to that seen during the spring.  
Thereafter, the GSI dramatically declined reaching 0.34 ± 0.0001, by the beginning of 
winter.  Surprisingly, GSI levels increased during the winter months, reaching a peak 
higher than that what was observed during the prespawning and spawning seasons in 
February (6.02 ± 0.02; Fig 6.1).  The only explanation I can offer is the fact that for two 
of the three years during which the recording of the GSI was done, we had very mild 
temperatures during the winter.  In addition, during 2004 we experienced a delayed 
spring, in which the temperatures were unseasonably low and could have had a marked 
affect on the GSI. 
C.  Discussion 
 The seasonal peaks in GSI in female goldfish collected from Hunting Creek 
Fisheries suggests that goldfish do not spawn only once a year, but are fractional 
spanwers, undergoing repeated oocyte maturation and release.  Similar evidence of 
multiple spawning in goldfish have been reported previously (Delahunty & de Vlaming, 
1980; Munkittrick & Leatherland, 1984).  However, these data contradict earlier studies 
which demonstrated only one peak in the GSI (Swee & MacCrimmon, 1966; Mahon & 
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Balon, 1977; Sohn et al.; 1999) or two peaks in the GSI (Munkittrick & Leatherland, 
1984).  There are several ways in which to explain the differences that were observed in 
this thesis with those reported earlier.  First, the goldfish utilized in many of these 
previous studies were much smaller than the goldfish presented in this thesis.  Second, 
these studies observed the seasonal changes in the gonadosomatic index for a one year 
period, where as, here we present data on the gonadosomatic index over a three year 
period.  Lastly, the data from all these studies were collected in different years and 
regions of the world.  Therefore, it is difficult to make clear and concise correlations with 
one another. 
 The data present in this thesis suggests that the gonadosomatic index alone is not 
an accurate measure of seasonal or experimental fluctuations in the gonadal state of 
goldfish.  Further experimentation in which measurements of mRNA levels of 
gonadotropin, regulates growth and development of ovary and testis, and thyrotropin, 
stimulates the thyroid gland to produce and secrete thyroid hormones, as well as 
measurements in the seasonal changes in the number, density and nuclear diameter of 
pituitary gonadotrophs in large and small goldfish should be conducting to develop a full 
and complete understanding the seasonal changes in goldfish. 
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Figure 6.1. Seasonal Changes in GSI in Goldfish 
The figure above represents the seasonal changes in the gonadosomatic index (GSI) in 
goldfish (Carassius auratus) over a 3 year period (2003-2006). 
 
 
Table 6.1.  Gonadosomatic indices (GSI) in goldfish during different 
periods of their reproductive cycle. 
 
Period of reproductive cycle GSI Female 
PRE (October – March) 2.82 ± 0.01 
LP (April – May) 4.64 ± 0.004 
HP (June – August) 4.12 ± 0.01 
POST (September) 2.27 ± 0.01 
 
 
 The data are shown as means ± SEM. 
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CHAPTER 7: CONCLUSIONS 
A.  Summary and Conclusions 
 The studies presented in this thesis specifically analyzed the influence of a 
neurosteroid, pregnenolone sulfate, on the normal, acquisition and retention phases of 
vestibulo-ocular reflex increase and decrease adaptation.  This work provided the 
opportunity to investigate the role of the cerebellum as a possible site of behavioral 
adaptation and provide new information regarding the biochemical processes of 
vestibulo-ocular reflex adaptation.  The objective of this research was to examine 
inhibitory and/or excitatory pharmacology of neural plasticity in the sensori-motor 
system in vivo, specifically the vestibulo-ocular reflex. 
    1.  Effect of PREGS on the Normal Vis-VOR and VOR Reflex (Microdialysis) 
 Increase Adaptation.  Microdialysis of the neurosteroid, PREGS (a GABAA 
antagonist and NMDA agonist; 100µM), into the vestibulo-cerebellum of goldfish prior 
to adaptation did not appear to have an effect on the normal gain of the reflex when 
compared to the pre-insertion gain.  In addition, the infusion of PREGS did not appear to 
alter the animals’ ability to increase the reflex when compared to the pre-insertion gain 
(Fig 7.1A). 
 Decrease Adaptation.  Microdialysis of the GABAA antagonist and NMDA agonist, 
PREGS (10µM), into the vestibulo-cerebellum of goldfish prior to adaptation did not 
appear to have an effect on the normal gain of the reflex when compared to the pre-
insertion gain.  In addition, the infusion of PREGS did not appear to alter the animals’ 
ability to decrease the reflex gain when compared to the pre-insertion gain (Fig 7.1B). 
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Figure 7.1. Effect of PREGS on Normal Reflex Increases and Decreases 
(Microdialysis) 
A) Illustrates that infusion of the optimal concentration of PREGS (10µM) did not appear 
to alter normal reflex gain or the animals’ ability to increase their reflex gain compared to 
pre-infusion gains.  B) Illustrates that infusion of 10µM of PREGS did not appear to alter 
normal reflex gain or the ability to decrease gain reflex compared to pre-infusion gains. 
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Figure 7.2. Effect of PREGS on Normal Reflex Increases and Decreases 
(Microinjection) 
A) Illustrates that infusion of PREGS (100µM) did not appear to alter normal reflex gain 
or the animals’ ability to increase their reflex gain compared to pre-infusion gains.  B) 
Illustrates that infusion of PREGS (100µM) did not appear to alter normal reflex gain or 
the ability to decrease gain reflex compared to pre-infusion gains. 
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    2.  Effect of PREGS on Normal Vis-VOR and VOR Reflex (Microinjection) 
 Increase Adaptation.  Bilateral microinjection of the neurosteroid, PREGS (a 
GABAA antagonist and NMDA agonist; 100µM), into the vestibulo-cerebellum of 
goldfish prior to adaptation did not appear to have an effect on the normal gain of the 
reflex when compared to the pre- insertion gain.  In addition, the infusion of PREGS did 
not appear to alter the animals’ ability to increase the reflex when compared to the pre-
insertion gain (Fig 7.2A). 
 Decrease Adaptation.  Bilateral microinjection of the GABAA antagonist and NMDA 
agonist, PREGS (100µM), into the vestibulo-cerebellum of goldfish prior to adaptation 
did not appear to have an effect on the normal operations of the reflex when compared to 
the pre-insertion gain.  In addition, the infusion of PREGS did not appear to alter the 
animals’ ability to decrease the reflex gain when compared to the pre-insertion gain (Fig 
7.2B). 
    3.  Effect of PREGS on the Acquisition Phase of VOR Adaptation (Microdialysis) 
 Increase Acquisition.  GABAA antagonism and/or NMDA agonist action by PREGS 
enhanced the acquisition of adaptive vestibulo-ocular reflex gain increases (Fig 3.4A).  
This enhancement was only seen for the intermediate concentrations of PREGS (1 & 
10µM).  The activation of the NMDA receptors and/or inhibition of the GABAA 
receptors by PREGS enhanced the increase adaptation for the entire 3 hour acquisition 
(learning) period.  These findings suggest that NMDA receptors and/or GABAA receptors 
are involved in vestibulo-ocular reflex adaptive gain increases. 
 Decrease Acquisition.  GABAA antagonism and/or NMDA agonist action by PREGS 
did not enhance nor inhibit the acquisition of adaptive vestibulo-ocular reflex gain 
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decreases (Fig 3.6B) for any concentration.  Activation of the NMDA receptors and/or 
inhibition of the GABAA receptors by PREGS did not have appear to have any effect for 
the entire 3 hour acquisition (learning) period and would suggest that activation of the 
NMDA receptors and/or inhibition of the GABAA receptors are not involved in adaptive 
gain decreases. 
    4.  Effect of PREGS on the Acquisition Phase of VOR Adaptation (Microinjection) 
 Increase Acquisition.  Activation of the NMDA receptors and/or inhibition of the 
GABAA receptors by PREGS, when microinjected into the vestibulo-cerebellum of 
goldfish, enhanced the acquisition of adaptive VOR gain increases (Fig.3.9A).  This 
enhancement was only seen at one concentration (100µM).  PREGS’ agonist action on 
the NMDA receptors and/or antagonistic action on the GABAA receptors enhance the 
increase adaptation for the entire 3 hour acquisition (learning) period.  These findings 
suggest that NMDA receptors and/or GABAA receptors are involved in vestibulo-ocular 
reflex adaptive gain increases. 
 Decrease Acquisition.  Activation of the NMDA receptors and/or inhibition of the 
GABAA receptors by PREGS, when microinjected into the vestibulo-cerebellum of 
goldfish, did not enhance nor inhibit the acquisition of adaptive VOR gain decreases 
(Fig.3.11B).  There appeared to be no effect on decrease adaptation for the entire 3 hour 
acquisition (learning) period for any concentration of PREGS.  These findings suggest 
that activation of NMDA receptors and/or inhibition of the GABAA receptors are not 
involved in vestibulo-ocular reflex adaptive gain decreases. 
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    5.  Effect of PREGS on Adaptive VOR Gain Increase After First Being Trained to 
Decrease Adaptive VOR Gains (Microdialysis) 
 Infusion of the two most significant concentrations of PREGS after 3 hours of 
adaptive decrease training followed by 3 hours of adaptive increase training did not 
appear to significantly reverse their learned decrease VOR gain (Fig 3.11).  These results 
supports the hypothesis that the mechanism and possible the site of adaptive VOR gain 
decreases is pharmacologically separate and distinct from adaptive VOR gain increases. 
    6.  Effect of PREGS on the Retention Phase of VOR Adaptation When Infused Before 
Acquisition 
 Adapted Increase Retention Phase.  Infusion of PREGS into the vestibulo-cerebellum 
before the acquisition phase did enhance adaptive VOR gain increases, however, by the 
end of the retention period the PREGS treated animals retained approximately the same 
percentage of their adapted increase as the control group (Fig 4.1A).  These studies would 
suggest that activation of NMDA receptors and/or inhibition of the GABAA receptors are 
not involved in the retention phase of VOR adaptation. 
 Adapted Decrease Retention Phase.  Infusion of PREGS into the vestibulo-
cerebellum before the acquisition phase did not appear to enhance adaptive VOR gain 
decreases nor did it appear to enhance/inhibit the retention phase (Fig 4.1B).  Animals 
treated with PREGS illustrated similar VOR decrease gains as controls by the end of the 
retention phase.  These studies would suggest that similar to retention increases the 
activation of NMDA receptors and/or inhibition of the GABAA receptors are not involved 
in the retention phase of VOR adaptation. 
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    7.  Effect of PREGS on the Retention Phase of VOR Adaptation When Infused After 
Acquisition 
 Adapted Increase Retention.  Infusion of PREGS into the vestibulo-cerebellum of 
goldfish after the acquisition phase (beginning of the retention phase) did not appear to 
enhance nor inhibit the adapted vestibulo-ocular reflex gain (Fig 4.2A).  These results 
suggest that activation of NMDA receptors and/or inhibition of the GABAA receptors are 
not involved in the retention phase of VOR adaptation.  
 Adapted Decrease Retention.  Infusion of PREGS into the vestibulo-cerebellum of 
goldfish after the acquisition phase (beginning of the retention phase) did not appear to 
enhance nor inhibit the adapted vestibulo-ocular reflex gain (Fig 4.2B).  These results 
suggest that activation of NMDA receptors and/or inhibition of the GABAA receptors are 
not involved in the retention phase of VOR adaptation.  
B.  Vestibulo-Ocular Reflex Adaptation and Pregnenolone Sulfate 
 The VOR stabilizes visual targets on the center of an animal’s visual field in order to 
maintain clear vision during rapid head motion by coordinating equal, but opposite eye 
movements with respect to the head.  Adaptation of the VOR occurs when there is a 
mismatch of the vestibular and visual stimuli.  Information regarding head position and 
velocity are transmitted by the cerebellar mossy fibers originating from the semi-circular 
canals, within the vestibulo-ocular reflex circuitry (Fig 7.4).  The mossy fibers activate 
Purkinje cells and inhibitory interneurons through synaptic connections with the granule 
cell-parallel fiber system.  Information regarding image slippage is transmitted by 
cerebellar climbing fibers that originate from the inferior olivary nucleus in the 
brainstem.  The climbing fibers make one-to-one synaptic connections with the Purkinje  
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Figure 7.3. Effects of PREGS on Vestibulo-Ocular Reflex Adaptation. 
A) The overall effect of the neurosteroid, pregnenolone sulfate (PREGS) on the 
acquisition (learning) phase vestibulo-ocular reflex adaptation.  B) and the retention 
(memory) phase of vestibulo-ocular reflex adaptation when infused into the vestibulo-
cerebellum of goldfish.  (n.e. represents no effect) 
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cell dendrites (Fig 7.4).  The Purkinje cells represent the sole output of the cerebellum 
and projects monosynaptic inhibitory (GABA) influence on vestibular neurons in the 
brainstem.  NMDA receptors are localized in the glomeruli/granule cell complex and 
inhibitory interneurons (basket and stellate cells) of the cerebellum.  Excitation of the 
NMDA receptors on these neurons enhances the transmission of information regarding 
head position and velocity to the Purkinje cells, thereby enhancing adaptation of the 
VOR. 
 Another possible mechanism of activation specific to the NMDA receptor involves 
the climbing fiber-Purkinje cell synapse (Fig 7.4).  NMDA receptors do mediate 
transmission on the proximal dendrite of Purkinje cells corresponding with climbing 
fiber-Purkinje cell synapses in adult guinea pig (Kimura et al.; 1985a, 1985b; Sekiguchi 
et al.; 1987; Billard & Pumain, 1989).  Excitation of these NMDA receptors by PREGS 
enhances the transmission of visual targets to the Purkinje cells and therefore enhances 
adaptation of the reflex.  However, functional NMDA receptors have been reported to 
disappear from Purkinje cells after 2 weeks of age in rats (Crepel et al.; 1983; Audinat et 
al.; 1990; Farrant & Cull-Candy, 1991; Krupa & Crepel, 1990; Lachamp et al.; 2005, 
Llano et al.; 1991; Dupont et al.; 1987; Metzger et al.; 2005).  The presence of cerebellar 
NMDA receptors in the Purkinje cells in goldfish has yet to be determined.  However, 
PREGS’ may mediate its effects through presynaptic NMDA receptors located at the 
parallel fiber-Purkinje cell synapse. 
 Another alternative possibility includes stimulation of the granule cell-parallel fiber 
synapse, resulting from changes in head position and acceleration causing an increase in 
Purkinje cell activity.  An increase in Purkinje cell activity produces a greater release of  
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Figure 7.4. Cerebellar Cortex 
Possible site(s) of action for pregnenolone sulfate could be at NMDA receptors localized 
in the glomeruli/granule cell complex and/or NMDA receptors localized at the climbing 
fiber-Parallel cell synapse.  Activation of these receptors by pregenenolone sulfate could 
cause a greater release of glutamate, causing enhancement of the reflex. 
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GABA onto relay neurons in the vestibular nuclei which in turns leads to modulation of 
the signal output to the oculomotor neurons leading to a change in eye position.  An 
inhibition of the GABAA receptor complex would produce a decrease in the release of 
GABA onto relay neurons in the vestibular nuclei leading to enhancement of the reflex. 
    1.  Increase Acquisition 
 In vestibulo-ocular reflex gain increase acquisition, the visual target moves twice the 
distance, but in the opposite direction to that of the head, producing additional retinal slip 
information during training, which results in greater climbing fiber stimulation.  
Vestibulo-ocular reflex gain increase adaptation occurs from simultaneous activation of 
the climbing and mossy fiber systems resulting from the mismatch of visual target, head 
position and acceleration information.  This simultaneous firing may lead to a 
potentiation at the parallel-fiber-Purkinje cell synapse, similar to that observed in long-
term potentiation (Petralia et a.; 1994; Casado et al.; 2000).  PREGS’ excitation of the 
NMDA receptors associated with the climbing fiber-Purkinje cell synapse would enhance 
the transmission of visual target information.  The vestibulo-ocular reflex is incapable of 
responding to changes in visual target information without this signal. 
 Alternate sites of action for PREGS on vestibulo-ocular reflex gain increase 
adaptation involve the mossy fiber-granule cell-parallel fiber network.  Information 
regarding head position and acceleration is transmitted by this network.  The mossy fibers 
make synaptic connections with the cerebellar glomeruli.  The output of these specialized 
granule cells goes to the parallel fibers where the information regarding head position and 
acceleration is carried to the Purkinje cells.  PREGS may be activating NMDA receptors 
located in the glomeruli producing a significant increase in the release of glutamate 
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and/or inhibiting the GABAA receptors located in the Purkinje cells producing a decrease 
in Purkinje cell activity, causing a decrease release of GABA onto the target vestibular 
neurons.  A decrease release of GABA would modulate the vestibular neuron signal 
output to the oculomotor neurons leading to a change in eye position. 
 PREGS has been demonstrated to act by facilitating the action of glutamate at 
presynaptic NMDA receptors (Gibbs et al.; 1999).  PREGS significantly modulated 
NMDA receptors at micromolar concentrations (Gibbs et al.; 1999).  In addition, PREGS 
has been shown to directly inhibit by low micromolar concentrations the GABAA 
receptor (Lambert et al.; 2003).  Moreover, GABA release in cultured hippocampal 
neurons was reported to have been reduced by nanomolar concentration of PREGS 
(Mtchedlishvili & Kapur, 2003).  Infusion of the GABAA receptor antagonist and/or 
NMDA agonist, PREGS, via microdialysis and microinjection into the vestibulo-
cerebellum of goldfish enhanced adaptive VOR gain increases.  The mechanism by 
which this was achieved was either through activation of the climbing fiber-Purkinje cell 
associated NMDA receptors, activation of the glomeruli/granule cell NMDA receptors, 
disinhibition of Purkinje cell activity, synergistic disinhibition of Purkinje cell activity 
and activation of NMDA receptors or conversion of PREGS into pregnenolone and other 
derivatives in the neurosteroid synthesis pathway. 
 Previous studies from our laboratory have demonstrated that infusion of the NMDA 
antagonist (D-AP5) inhibited adaptive VOR gain increase, but not gain decreases (Carter 
& McElligott, 1995.  In addition, infusion of the GABAA agonist (muscimol) inhibited 
both adaptive VOR gain increases and decreases.  Also, infusion of the neurosteroid, 
estradiol, enhanced adaptive VOR gain increases, but not gain decreases.  The studies 
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presented in this thesis demonstrated that the effect of PREGS on the VOR was opposite 
to the results found using D-AP5, but affecting the same adaptive conditions.  Therefore, 
one might surmise that PREGS’ agonist action on the NMDA receptor is the cause of the 
observed enhancement of the VOR adaptive gain increases.  In addition, the data 
presented in this suggest that only VOR adaptive gain increases require activation of 
NMDA receptors. 
 Recently, it has been demonstrated that transient presynaptic NMDA receptor-
dependent increase of glutamate release induced by PREGS was followed by a long-
lasting strengthening of postsynaptic AMPA receptor mediated transmission that 
resembles long term potentiation (Mameli et al.; 2005).  Therefore, a localized elevation 
in Ca2+ influx through NMDA receptors could be responsible for the induction of 
plasticity.  The Ca2+ elevation could activate protein kinases, such as cAMP-dependent 
protein kinase, which phosphorylates AMPA receptors and increases their conductance 
(Wang et al.; 1991; Banke et al.; 2000; Yasuda et al.; 2003).  Alternatively, Ca2+ could 
induce the delivery of AMPA receptors to active synapses already expressed in these 
receptors or to silent synapses lacking AMPA receptors (Isaac, 2003; Malinow, 2003).  
These findings indicate that the pharmacological mechanism of adaptive vestibulo-ocular 
reflex gain increases has similar characteristics to that of LTP. 
    2.  Decrease Acquisition 
 In vestibulo-ocular reflex gain decrease acquisition, the goldfish tracks a visual 
target that moves exactly with the head, thereby reducing image slip feedback 
information (du Lac & Lisberger, 1992).  By experimental design, cerebellar climbing 
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fiber activity is reduced, suggesting that control of decrease adaptation lies either with the 
glomeruli input to the parallel fibers and/or parallel fiber-Purkinje cell synapse. 
 Previously, our laboratory demonstrated that infusion of the GABAA agonist, 
muscimol, inhibited adaptive VOR gain decreases.  In addition, inhibition of the NMDA 
receptors by the NMDA antagonist, D-AP5, had no lasting effect on the decreased 
adaptation.  Moreover, the infusion of the neurosteroid, estradiol, did not inhibit nor 
enhance adaptive VOR gain decreases.  The results of the studies presented in this thesis 
demonstrated that infusion of the GABAA receptor antagonist and/or NMDA agonist, 
PREGS, via microdialysis and microinjection into the vestibulo-cerebellum of goldfish 
did not appear to enhance nor inhibit adaptive VOR gain decreases.  This suggests 
several things (1) that activation of the NMDA receptors is not required for VOR 
adaptive gain decreases, (2) the probable site of action for PREGS is at the cerebellar 
glomeruli, (3) the mechanisms involved in adaptive VOR gain increases and gain 
decreases are pharmacologically distinct from each other and (4) that the site of adaptive 
changes may not involve the cerebellum. 
    3.  Increasde Versus Decreasde Acquisition 
 The most obvious explanation for the differences observed between VOR adaptive 
gain increases and decreases is that these two acquisition task are pharmacologically 
separate and distinct from each other and/or their site of adaptation involves predominant 
control for different anatomical structures (i.e., cerebellum = gain increases; vestibular 
nuclei = gain decreases) despite similar reflex circuitry. 
 However, previous experiments in the goldfish from our laboratory have 
demonstrated that the cerebellum is at least partially involved in the adaptive VOR gain 
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decreases.  Microdialysis of muscimol into the vestibulo-cerebellum of goldfish inhibited 
adaptive VOR gain decreases.  In addition, bilateral microinjection of the non-NMDA 
antagonist, 6-cyano-7-nitroquinoxaline-2,3 dione (CNQX) into the vestibulo-cerebellum 
of goldfish prevents decrease adaptation (Carter & McElligott, 2005).  Also, 
cerebellectomy (Pastor et al.; 1994) and lidocaine administration into the vestibulo-
cerebellum of goldfish (McElligott, 1995) demonstrated elimination or prevention of 
decreased adaptation, respectively. 
 Further experimentation is needed to determine if NMDA receptors are involved 
with adaptive VOR gain decreases at the level of the vestibular nuclei.  Moreover, studies 
that involve NMDA receptors role in Ca2+ influx in both the cerebellum and vestibular 
nuclei may provide useful information regarding adaptive VOR gain decrease changes, 
since Ca2+ entry is responsible for LTP at excitatory synapses (Casado et al.; 2000). 
    4.  Increase Retention 
 The effects produced by PREGS when infused following the acquisition period, 
would indicate that the mechanisms involved in acquisition (learning) and retention 
(memory) are pharmacologically separate and distinct and/or their site of adaptation 
involves predominant control for different anatomical structures.  In adaptive gain 
increase experiments, the GABAA antagonist and/or NMDA agonist (PREGS) neither 
enhanced nor inhibited the retention phase of VOR adaptive gain increases.  These results 
demonstrate that NMDA activation and/or inhibition of the GABAA receptor may not be 
necessary for the normal retention of an adapted gain increase.  Furthermore, these results 
suggest that the cerebellum may not be a necessary structure for memory storage of an 
adapted gain increase. 
  
121 
 Experimentally, PREGS has been shown to affect retention when administered 
systemically after the acquisition phase in several spatial memory paradigms (Flood et 
al.; 1992, 1995; Frye & Sturgis 1995; Isaacson et al.; 1995; Mathis et al.; 1996; Mezine et 
al.; 1996).  The studies presented in this thesis demonstrate that the role of PREGS on the 
retention aspect of adaptation is varied and depends on brain region, specific learning 
task involved and administration of the drug.  As mentioned previously, the results of this 
thesis suggest that activation of the NMDA receptors and/or inhibition of the GABAA 
receptor may not be necessary for normal retention of an adapted VOR gain increases.  
However, studies in our laboratory have demonstrated that the infusion of the GABAA 
agonist, muscimol, or the NMDA antagonist, D-AP5, inhibited the normal retention of 
adapted VOR gain increases.  This suggests that these receptors are necessary for 
retention of adapted VOR gain increases. 
 A possible mechanism of action is that PREGS is inversely modulating the NMDA 
receptors (Monnet et al.;1995) while simultaneously blocking the GABAA receptors.  
Information regarding head position and acceleration is carried by the cerebellar mossy 
fibers originating from the semi-circular canals, which activate Purkinje cells and 
inhibitory interneurons through synaptic connections with granule cells-parallel fibers.  
Inhibition of NMDA receptors in the glomeruli/granule cell complex would prevent the 
transmission of information regarding head position and acceleration to the Purkinje 
cells, while inhibition of the GABAA receptors in the glomeruli/granule cell complex 
would lead to an enhancement of the transmission of information regarding head position 
and acceleration to the Purkinje cell; effectually canceling each other out and resulting in 
neither inhibition nor enhancement of the reflex. 
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    5.  Decreased Retention 
  The results obtained from these studies in this thesis demonstrated that the PREGS 
animals trained to an adapted decrease gain retain their adapted VOR gain for the entire 3 
hour retention period.  Similar results have been illustrated from our laboratory in which 
infusion of the NMDA antagonist, D-AP5, neither inhibited nor enhanced the normal 
retention for adapted gain decreases.  The summation of these studies suggests that the 
mechanism of action for retention of an adapted gain decrease is similar to that of 
decrease acquisition.  In addition, it can be suggested that the mechanism of decrease 
retention does not require the activation or inhibition of NMDA receptors. 
    6.  Increase Versus Decrease Retention 
 The differences observed between vestibulo-ocular reflex gain increase and decrease 
during the retention phases suggests two things.  (1) the mechanism of memory storage 
may involve a redistribution of information between different parts of the brain, a transfer 
of a learned VOR gain change from the cerebellum to the vestibular nuclei (Galiana, 
1986; Nagao & Kitazawa, 2003; Peterson et al.; 1991).  (2) these two tasks may require 
different neuronal circuits.  Previous studies from our laboratory have implicated the 
cerebellum, its glutamate receptors (NMDA and non-NMDA) in the retention of an 
adapted gain increase.  However, the data presented in this thesis does not implicate those 
NMDA receptors as being necessary for the retention of adapted gain increase or 
decrease.  Further experimentation is necessary to determine the mechanism of retention 
for an adapted VOR gain change in the cerebellum and vestibular nuclei.  Also, further 
studies should be performed to identify the role of GABAA and NMDA receptors on the 
retention phase of increased and decreased adaptation. 
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C.  Cytochrome P450scc 
 Previous studies have demonstrated the presence of P450scc-like protein in both 
higher and lower vertebrates, suggesting that cytochrome P450scc is evolutionarily well 
conserved.  The present investigation demonstrated that a cytochrome P450scc-like 
protein was localized in the brain of goldfish, Carassius auratus.  The results in this 
thesis illustrate that a cytochrome P450scc-like protein was localized in the cerebellum of 
goldfish, specifically in the Purkinje cell layer (Fig. 5.1).  These results suggest that 
cytochrome P450scc and the enzymatic mechanism involved in the formation of 
pregnenolone is evolutionarily well conserved.  In addition, these findings suggests the 
formation of pregnenolone and pregnenolone sulfate in the cerebellum of goldfish since 
cytochrome P450scc was localized in neurons in the brain, specifically the Purkinje cell 
which is a typical cerebellar neuron. 
D.  Neurosteroids and Disorders of Learning and Memory 
 Neurosteroids have been implicated in the pathogenesis of Alzheimer’s disease a 
neurodegenerative disease (Kim et al.; 2003, Schumacher et al.; 2003; Weill-Engerer et 
al.; 2002, 2003).  However, the exact involvement of neurosteroids has not been 
determined.  It has been demonstrated that in Alzheimer’s patients there was a 
significantly lower concentration of neurosteroids in several brain regions and 
neurosteroid levels were negatively correlated with two biochemical markers of 
Alzheimer’s disease, the phosphorylated tau protein and the β-amyloid peptides. 
 Studies have also been done to determine the level of neurosteroids in the cerebral 
spinal fluid (CSF) of Alzheimer’s patients.  In two studies the levels of pregnenolone and 
PREGS in the CSF did not differ significantly from those reported in human serum 
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(Tagawa et al.; 2001; de Peretti & Mapus, 1983).  Other studies have reported that the 
overall levels of certain neurosteroids, including pregnenolone and PREGS, in different-
aged human brain regions were 2 orders of the magnitude higher than the levels found in 
the CSF (Lanthier & Patwardhan, 1986; Lacroix et al.; 1987; Weill-Engerer et al.; 2002).  
Recently it has been demonstrated the levels of neurosteroids in the CSF of Alzheimer’s 
patients were significantly increased and decreased with respect to controls (Kim et al.; 
2003). 
 Steroids offer interesting therapeutical opportunities for promoting successful aging, 
but much more experimental testing and research needs to be done if they are to used as a 
treatment strategy for disorders/dysfunctions of learning and memory. 
E.  Goldfish Vestibulo-Ocular Reflex Compared to Mammalian Systems 
 As mentioned previously (Chapter 1-Introduction), the anatomical organization of 
the goldfish vestibulo-ocular reflex shares many similarities with mammals (Pastor et al.; 
1992, 1994).  The vestibulo-cerebellum of the goldfish is comparable to the flocculus in 
the mammalian system.  The afferent and efferent organization, as well as, the basic 
firing patterns of the Purkinje cells in this region are similar to those found in mammals 
(monkeys; Lisberger & Fuchs, 1978; Miles et al.; 1980; Wantanabe, 1984).  The brain 
stem oculo-motor organization in goldfish, however, differs from mammals.  The 
vestibular nuclei of the goldfish associated with horizontal eye movements are called the 
descending octaval nucleus.  Four distinct brain stem nuclei have been identified in the 
goldfish that function as eye position and velocity integrators (from caudal to rostral: 
Area I, II, III and IV; Pastor et al.; 1994).  Area II receives visual and vestibular 
information and projects to the vestibular nucleus and the vestibulo-cerebellum.  This 
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area also stores and produces eye velocity signals.  Cerebellar Purkinje cells in goldfish 
also project into this region.  Pastor et al.; (1994) proposed that in goldfish, Area II may 
be one brain stem loop that supports the direct vestibulo-ocular reflex pathway.  Area II 
in goldfish appears to be homologous to the prepositus hypoglossi nucleus, the site of 
interaction between the visual and vestibular systems in mammals.  In contrast to other 
animals, goldfish produce large and rapid adaptive vestibulo-ocular reflex gain changes. 
 The cerebellar cortex is composed of five main types of neurons, granule cells 
(located in the granule layer), Purkinje cells (located in the Purkinje cell layer) and three 
types of inhibitory interneurons, the Golgi cells, the stellate and basket cells (found in the 
molecular layer).  GABAA subunits have been demonstrated to be expressed in both the 
granule and Purkinje cell layers.  Functional NMDA receptors have been localized in the 
glomeruli/granule cell complex.  The studies reported in this thesis (Chapter 3) indicate 
that cerebellar GABAA and/or NMDA receptors are located in the goldfish vestibulo-
cerebellum and that they play a role in vestibulo-ocular reflex adaptation. 
F.  Conclusions 
 The findings described in this thesis confirm that the cerebellum is essential for 
vestibulo-ocular reflex adaptation and more specifically that activation of the NMDA 
receptors and/or inhibition of the GABAA receptors plays a role in this adaptation.  
However, this work disagrees with Ito’s model for the VOR which states that increases 
and decreases in adaptive VOR gain share similar properties due to their shared 
mechanism (Ito et al. 1972, 1982).  The studies presented here (Chapter 3) demonstrated 
that only adaptive vestibulo-ocular reflex gain increases were enhanced by the infusion of 
PREGS into the vestibulo-cerebellum of goldfish.  In addition, it was demonstrated that 
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PREGS could not significantly reverse decreases in VOR gains, suggesting that the 
pharmacological mechanisms involved in adaptive VOR gain increases and decreases are 
separate and distinct.  Moreover, these studies suggest that the mechanism involved in 
adaptive vestibulo-ocular reflex gain increases is similar to LTP. 
 The results present in Chapter 4 were markedly different from the memory-
enhancing effects of PREGS reported in other behavioral studies (Isaacson et al.; 1995; 
Flood et al.; 1992 &1995; Frye et al.; 1995; Meziane et al.; 1996; Mathis et al.; 1994 & 
1996; Cheney et al.; 1996; Melchoir & Ritzmann, 1996).  These results agree with Marr’s 
hypothesis that consolidation of memory may involve the redistribution of information 
between different parts of the brain.  Thus the role of the cerebellum may change with 
time after acquisition of learning; the motor memory for a learned change in VOR gain is 
transferred from the cerebellar cortex to the vestibular nuclei (Galiana, 1986; Nagao & 
Kitazawa, 2003; Peterson et al.; 1991).  However, previous studies from our laboratory 
have implicated the cerebellum, its glutamate receptors (NMDA and non-NMDA) in the 
retention of an adapted gain increase.  The data presented in this thesis does not implicate 
those NMDA receptors as being necessary for the retention of adapted gain increase or 
decrease.  However, further experimentation is still needed to elucidate the anatomical 
site(s) and mechanisms involved in vestibulo-ocular reflex adaptation. 
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APPENDIX A: ABBREVIATIONS 
 
 
 
 
Ach     Acetylcholine 
 
 
ACTH     Adrenocorticotrophic hormone 
 
 
AMG     aminoglutethimide 
 
 
AMPA     amino-3-hydroxy-5-methyl-4-isoxazole propionate 
 
 
ANOVA    analysis of variance 
 
 
β-CCE     ethyl- β-carboline-3-carboxylate 
 
 
BW     body weight 
 
 
°C     Celsius 
 
 
Ca+2     calcium ion 
 
 
cAMP     cyclic adenosine monophosphate 
 
 
CB     cerebellum 
 
 
CF     climbing fiber 
 
 
cGMP     cyclic guanosine monophosphate 
 
 
Cl-     chloride ions 
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cm     centimeter 
 
 
CNQX     6-cyano-7-nitroquinoxaline-2,3 dione 
 
 
CN     central nervous system 
 
 
CPP     3-((±)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid 
 
 
CSF     cerebrospinal fluid 
 
 
cytochrome P450scc  cytochrome P450 side-chain cleavage enzyme 
 
 
D,L-AP3   D,L-2amino-3-phosphonopropentanoic acid 
 
 
D-AP5     D-2-amono-5- phosphonopropentanoic acid 
 
 
DAB     diaminobenzidine 
 
 
DAG     diacylglycerol 
 
 
DHEA     dehydroepiandrosterone 
 
 
DHEAS    dehydroepiandrosterone sulfate 
 
 
dia.     diameter 
 
 
DNQX     6,7-dinotroquinoxaline-2,3-dione 
 
 
mEPSC    miniature excitatory postsynaptic current 
 
 
FFT     Fast Fourier Transform 
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fig.     figure 
 
 
GABA     Gamma-aminobutyric acid 
 
 
GSI     gonadosomatic indiex 
 
 
h, hr     hour 
 
 
H202     hydrogen peroxide 
 
 
HP     high spawning period 
 
 
Hz     Hertz 
 
 
IP3     inositol triphosphate 
 
 
IPSP     inhibitory post-synaptic potential 
 
 
K+     potassium ion 
 
 
KA     kainic acid 
 
 
KS     Kolmogorov-Smirnov 
 
 
LP     low spawning period 
 
 
LTD     long-term depression 
 
 
LTP     long-term potentiation 
 
 
µ     microns 
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µL     microLiter 
 
 
µM     microMolar 
 
 
Mg+2     magnesium ion 
 
 
mGluR    metabotropic glutamate receptor 
 
 
min     minute 
 
 
MK-801    dizocilpine maleate 
 
 
mM     millimolar 
 
 
mm     millimeter 
 
 
mV     millivolt 
 
 
mol     moles 
 
 
MNV     medial vestibular nucleus 
 
 
MS222    ethyl-3-aminobenzoate methansulfonate salt 
 
 
MUS     muscarinic receptor 
 
 
n     number of animals 
 
 
N.S.     not significant 
 
 
Na+2     sodium ion 
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NBQX     2,3-dihydro-6-nitro-7-sulfamoyl-benzo(F)quinoxaline 
 
 
NE     norepinephrine 
 
 
NIC     nicotinic receptor 
 
 
NMDA    N-methyl-D-aspartate 
 
 
NO     nitric oxide 
 
 
NOS     nitric oxide synthase 
 
 
P     P-value 
 
 
PB     phosphate buffer 
 
 
PC     Purkinje cells 
 
 
PI     phospoinostide 
 
 
PKA     protein kinase A 
 
 
PKC     protein kinase C 
 
 
POST     post-spawning period 
 
 
PRE     preparatory period 
 
 
PREGS    pregnenolone sulfate 
 
 
RIA     radioimmunoassay 
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SEM     standard error of the mean 
 
 
SSP     secondary spawning period 
 
 
StAR     steriodegenic acute regulatory protein 
 
 
trans-ACPD  trans-1-amino-cyclopentyl-1,2-dicarboxylic acid 
 
 
TS     titanic stimulation 
 
 
VC     valula cerebelli 
 
 
VDCC     voltage dependent calcium channels 
 
 
Vis-VOR   visual vestibulo-ocular reflex 
 
 
VL     vagal lobe 
 
 
VOR     vestibulo-ocular reflex 
 
 
vs     versus 
 
 
Zn+2     zinc ion 
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APPENDIX B: DEFINITIONS  
 
 
 
 
Vis-VOR  operation of the vestibulo-ocular reflex in conjuction with the visual sytem 
    (i.e. operation of this reflex in the light) 
 
 
VOR    measure of the internal vestibular system with no additional input from the 
    visual system (i.e. operation of this reflex in the dark) 
 
 
Normal   operation of the vestibulo-ocular reflex prior to modification/adaptation 
 
 
Acquisition progressive change in the gain during the training period (i.e. learning) 
 
 
Retention  maintenance of the learned gain after training has been completed (i.e. 
    memory) 
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